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Abstract 
ABSTRACT 
Cardiovascular disease (CVD), one of the most common causes of death among 
developed countries, results mainly from atherosclerosis. Atherosclerosis defines a 
disease in which the arterial wall becomes thickened and loses elasticity. The 
pathophysiology of atherogenesis includes the oxidation of low-density lipoprotein (LDL) 
by free radicals to oxidized LDL (OxLDL)，recruitment of monocytes into the artery wall 
and their transformation into macrophages, uptake of OxLDL by macrophages, foam 
cells formation, and finally the narrowing of blood vessel by foam cells and fatty streak. 
The vasodilative function of blood vessel will then be impaired due to the dysfunction of 
endothelium cells, which leads to hypertension. This silent disease will in turn result in 
several heart diseases such as cardiac ischemia. 
Danshen and Gegen have long been used in Chinese medicine to treat coronary 
heart diseases particularly for myocardial infarction and suspected to have cardiovascular 
tonic effects. Danshen is Radix Et Rhizoma Salviae Miltiorrhiza. Gegen has two species: 
Pueraria lobata (Willd.) Ohwi (Yege) and Pueraria thomsonii Benth (Fenge). In this 
project, comparisons of cardiovascular tonic effects of compound formulae 
(Danshen-Yege and Danshen-Fenge) water extract as well as extracts of two Gegen 
species were studied. 
Based on the pathology of atherosclerosis and hypertension, the vasodilative 
effect, antioxidative effect and the protective effect on ischemia reperflision injured heart 
of selected herbal extracts were studied. 
The weight ratio of Danshen and Fenge was first screened by their efficacy in 
inhibiting oxidant-induced 2,2'-azobis(2-amidinopropane)dihydrochloride (AAPH) red 
blood cell hemolysis. The compound formula of Danshen and Fenge aqueous extract at 
7:3 (w/w) was selected. In ex vivo vasodilative study, D:F (7:3) showed dose-dependent 
and synergistic vasodilative effects. Fenge and Yege aqueous extracts were found to have 
similar vasodilative mechanisms while Yege had superior potency. Both of them had 
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endothelium-dependent vasodilative effects mediated by nitric oxide synthase pathway, 
verified by using aorta without endothelium, adding L-NAME and ODQ, the inhibitor of 
nitric oxide synthase and soluble guanylyl cyclase, respectively. Their vasodilative effects 
were also partially reversed by 4-aminopyridine, barium chloride and 
tetraethylammonium. The stimulation of the voltage-sensitive K+ (Ky) channel and 
voltage-dependent inward rectifier K+ (KIR) channel were responsible for the vasodilative 
effect ofFenge and Yege. The effect of Danshen, however, was endothelium-independent 
and suspected to partially involve the opening of potassium channels. Daidzin and 
salvianolic acid B were potential active compounds for vasodilation from Fenge and 
Danshen, respectively. 
In the ischemia reperfusion injury protective test, the tested-concentration of 
herbal extracts did not recover the contractile force and coronary flow rate of heart. They 
also showed negative effect in reducing the leakage of lactate dehydrogenase and creatine 
kinase 
In the HPLC chromatographs analysis, the chemical profiles of Fenge and Yege 
were compared. 3'-hydroxypuerarin and 3'-methoxypuerarm were only found to exist in 
Yege. They will be focused for cardiovascular tonic activities tests based on the fact that 
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Chapter 1 Introduction 
1.1 Chinese Medicine and Western Medication 
Scientific progress and medical advancements have extended human's life span. 
In spite of medical progress, modem medical science has been almost powerless to 
cope with the rise of degenerative diseases that impact the industrial world. 
Modem medicine or western medication is effective in treating acute diseases. 
However, drugs usually are synthetic analogs and have serious side effects, which are 
harmfiil to the human body. The most common chronic and degenerative diseases 
nowadays include cancer, asthma, high blood pressure, arteriosclerosis, chronic 
hepatitis, rheumatism, diabetes mellitus and heart disease. Although both Modem 
medical science and Chinese medicines have not developed perfect therapeutic 
methods for curing these diseases, when Chinese medicines are applied to these 
diseases, they can at least cure the diseases or significantly reduce the pain (Chinese 
Herbal Medicine, 1987) with lesser side effects. It is by the fact that they are mostly 
natural product with milder effects. 
The basic theories of Chinese medicines are found in the Yellow Emperor 's 
Classic of Internal Medicine (Huang ti nei ching), the Treatise on Ferile Diseases 
(Shang han lun), and Summaries of Household Remedies (Chin Kuei yao lueh). The 
latter two were written nearly two thousand years ago. Since then these theories have 
evolved into Chinese medicine as it is still practiced today. The basic principles of 
treatment are derived from the theory that diseases occur as a consequence of 
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imbalance between normal vitality and toxic substances which have accumulated in 
human body. 
Western medicine is highly analytical and separates the human body into its 
component parts. It derives appropriate therapies based on traditional clinical trials 
research. Practitioners of modem medicine concentrate on identifying the disease by 
isolating it to a single cause, then healing that specific area of the body. Chinese 
medicine, on the contrary, is based on comprehensive whole body treatment. Chinese 
herbalist pays special attention to the patient's subjective complaints or conformation 
and then prescribes a holistic treatment on a subjective basis. 
The long history and lesser side effect of using Chinese medicine make it easily 
accepted among the people. It is valuable to develop this tradition Chinese wisdom 
with modem technologies (modernization). 
1.2 Chinese Medicine and Compound Formula 
The application of compound formula in Chinese medicine is the major difference 
between itself and western medicine. Usually, the Chinese herbalist combines many 
herbs depending on the condition of an individual case. It is one of the characteristics 
of Chinese medicine. Moreover, the different combination of herbs may contribute to 
synergistic effects. 
In this project, the popular herbs used in Traditional Chinese Medicine (TCM): 
Pueraria lobata (Willd.) Ohwi (Yege, in Pinyin name), Pueraria thomsonii Benth 
- 2 -
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(Fenge, in Pinyin name) and Radix Salviae miltiorrhizae (Danshen, in Pinyin name) 
arouse our interest to study their potential for treating cardiovascular related diseases. 
Notes: In Traditional Chinese Medicine, Pueraria lobata (Willd.) Ohwi (Yege) and 
Pueraria thomsonii Benth (Fenge) were classified as two variants of the same Herbs 
'Gegen’. 
1.2 Herbs Use for Treating Cardiovascular Disease (CVD) in Traditional Chinese 
Medicine 
Danshen and Gegen have long been used in Chinese medicine to treat coronary 
heart diseases particularly for myocardial infarction and suspected to have 
cardiovascular tonic effects. Danshen comes from Radix Et Rhizoma Salviae 
Miltiorrhiza. Gegen has two species or variants: Pueraria lobata (Willd.) Ohwi (Yege) 
and Pueraria thomsonii Benth (Fenge). In this project, comparisons of cardiovascular 
tonic effects of compound formulae (Danshen-Yege and Danshen-Fenge) water 
extracts as well as extracts of two Gegen species will be studied. 
1.2.1 Pueraria lobata (Willd.) Ohwi (Yege) and Pueraria thomsonii Benth (Fenge) 
Radix Puerariae is one of the most popular traditional herbs. It is commonly 
employed to relieve fever and dysentery, promote the production of body fluid, 
facilitate eruption, and lessen stiffness and pain of the nape (Jiangsu New Medical 
College, 1986). Recently, its use of Radix Puerariae for the treatment of coronary heart 
diseases such as hypertension, myocardial infraction and arrhythmia, has drawn 
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attention (Zheng et al, 1998). 
Two species, namely Fenge and Yege, have been officially included in Chinese 
Pharmacopoeia (1995 edition) under the same name Radix Puerariae (Committee for 
the Pharmacopoeia of P. R. China, 2000). In addition to their clinical applications, the 
former is widely used as a soup material in southern China and the latter has been 
prepared as a dietary supplement (Prasain et al, 2003). Thus both of them have entered 
human diet as a health supplement. Previous phytochemical investigations intended to 
characterize the bioactive components were mainly focused on Yege (Kinjo et al, 1987, 
Fang et al, 1974), and three well-known isoflavones, daidzein, daidzin and puerarin 
were identified as the principal active constituents. Daidzein was found to show potent 
antithrombotic activities (Choo et al, 2002)，daidzin was reported to possess 
spasmolytic activity (Nakamoto et al 1977), and puerarin was found to exhibit 
anti-hypertensive and anti-arrhythmic activity (Chai et al, 1985). It also acted as a 
P-adrenoreceptor antagonist in isolated arteries and veins (Wang et al, 1994). However, 
no comparative study on the cardiovascular tonic effects between Yege and Fenge has 
been reported. 
Notes: In the latest version of Chinese Pharmacopoeia (2005 edition), Yege was 
classified as 'Gegen'. Fenge was classified as another type of herb. 
1.2.2 Radix Et Rhizoma Salviae Miltiorrhiza. (Danshen) 
Danshen, the dried root of Salvia Miltiorrhiza Bge.，is a very important traditional 
Chinese medicine that promotes blood flow, stimulate menstrual discharge, and ease 
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the mind. (Pharmacopoeia of the People's Republic of China, 2000 edition). Modem 
pharmacological and clinical studies showed that Radix Et Rhizoma Salviae 
Miltiorrhiza has curative effects in cardiovascular disease (Guo, 1992). In China, 
Radix Et Rhizoma Salviae Miltiorrhiza is widely used in many preparations of Chinese 
medicines. The onsumption of this crude drug was estimated at about 80 million 
kilogram a year in China. 
Danshen has been used extensively for the treatment of coronary artery diseases, 
angina pectoris, myocardial infarction, cerebrovascular diseases, various types of 
hepatitis, chronic renal failure, dysmenorrhea!, and also to improve microcirculation in 
human studied (Jiang et al, 2005). It has also been proved to have an inhibitory effect 
on superoxide generation by microglias (Koo, 2004). The components from this herb 
were widely studied for many years. For example, salvianolic acid B (SAB), one of the 
water-soluble compounds from Danshen was studied for its inhibitory effect for 
shear-induced platelet aggregation in rat (Li et al, 2004). 
Apart from SAB, the biological effects of many compounds from Danshen were 
purified and studied, such as tanshinones I, tanshinones IIA, tanshinones IIB, 
protocatechualdehyde, salvianolic acid B and lithospermic acid. Tanshinones IIA was 
found to have potential anticancer activity on breast cancers (Wang et al, 2005). 
Protocatechualdehyde, on the other hand, was investigated as a potential agent for 
treatment of pigmentation disorder. (No et al, 2004). 
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1.3 Cardiovascular Disease (CVD) and Atherosclerosis 
Cardiovascular disease is a term which describes diseases of the heart and blood 
vessels. The common types include angina, heart attack (the technical term is 
myocardial infarction), disease of the heart valves or heart muscle (the latter called 
cardiomyopathy), heart failure, stroke and pain from poor blood flow to the legs 
(called claudication). 
The single most common cause of these disease is ‘hardening’ of the arteries 
(called atherosclerosis). This can be prevented to a large extent and because of this, it 
is important to be aware of the major risk factors which will be discussed later. 
Due to the high pressure lifestyle and fast food diets of people nowadays, the 
number of cases of cardiovascular disease is increasing in Hong Kong as well as 
around the world. According to the Hospital Authority of Hong Kong, cardiovascular 
disease is the second leading cause of death in 2001 while it is the first killer around 
the world. (Census and statistics department, Department of Health, 2001) 
Cardiovascular disease results mainly from the process of atherosclerosis. 
Atherosclerosis (ath"er-o-skleh-RO'sis) comes from the Greek words athero (meaning 
gruel or paste) and sclerosis (hardness). It defines a disease in which the arterial wall 
becomes thickened and loses elasticity. The pathophysiology of atherogenesis 
comprises of various important steps (Figure 1.1), including the oxidation of 
low-density lipoprotein (LDL) by free radicals (1) to oxidized LDL (OxLDL) (2), 
recruitment of monocytes into the artery wall (3) and their transformation into 
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macrophages, uptake of OxLDL and cholesterol by macrophages, foam cells formation 
(4)，and finally the narrowing of blood vessel by foam cells and fatty streak / plaque 
(5). This plaque may partially or totally block the blood's flow through the artery. This 
process can then cause bleeding into the plaque or the formation of a blood clot which 
can ultimately block the entire artery. In both cases, the disease may ultimately result 
in a stroke or heart attack. 
The vasodilative function of blood vessel will then be impaired due to the 
dysfunction of endothelium cells, which leads to hypertension. This silent disease will 
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Figure 1.1 The Pathology of Atherosclerosis 
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1.3.1 Common Forms of Coronary Heart Disease (CHD) 
Cardiovascular disease includes all forms of coronary heart disease (CHD). The 
two most common forms of CHD are heart attack and heart failure. 
Myocardial infarction (MI), the medical term for heart attack and sometimes 
referred to the interception of the flow of oxygenated blood to the heart muscle either 
by blockage, obstruction from a blood clot, or a sudden constriction or spasm. If the 
blood is cut off for a long time, muscle cells in the heart will die, leading to various 
degrees of disability and even death. New drugs called thrombolytic agents may allow 
physicians to actually interrupt the course of the heart attack, but health care providers 
must be knowledgeable in their use. Tools to beat heart disease include drugs such as 
beta blockers as well as the modification of unhealthy lifestyle factors. 
Heart failure, another type of coronary artery disease, results when the heart's 
ability to pump efficiently is impaired. The heart muscle may be damaged or 
overworked by a number of causes such as high blood pressure, heart attack, 
atherosclerosis, rheumatic fever, congenital defects, or cardiomyopathy (heart muscle 
disease). Usually the heart fails over time. Ultimately, this causes symptoms such as 
shortness of breath. Most causes are treatable, with the ultimate intervention being 
heart transplant. 
Angina pectoris (chest pain) also deserves mentioning as the most common 
symptom associated with CAD. Sudden physical exertion or emotional excitement can 
trigger an angina attack which usually lasts for 5 to 10 minutes and is relieved by 
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Stopping the activity, resting, or drugs such as nitroglycerine. Because angina occurs 
when the heart muscle does not get as much oxygen from the blood as is needed to 
function, it can be a warning sign of heart attack risk. If angina continues and is 
unrelieved by nitroglycerine, a heart attack may occur. 
1.3.2 Risk Factors of Cardiovascular Disease 
Risk factors are that make people more likely to develop a disease. There are two 
types of risk factors. Non-modifiable risk factors are those that cannot be changed, 
while modifiable risk factors can be changed if the individual is willing to alter 
lifestyle, habits, diet, etc. 
1.3.2.1 Non-Modifiable Risk Factors 
Prevention of coronary artery disease, the chief form of cardiovascular disease, 
depends on the identification of risk factors in individuals who have no symptoms or 
complaints. Non-modifiable risk factors for coronary heart disease, those that cannot 
be changed, include age, sex and heredity. (Information from ‘American Re，， 
http://www.amre.com/) 
Age 
參 4 out of 5 people who die of heart attack are 65 years or older. 
• 45 percent of heart attacks occur in people under age 65 years. 
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• 80 percent of coronary mortality in people under 65 years occurs during the initial 
attack. 
Sex 
參 Males are generally at greater risk than females. 
參 After menopause, women's death rate from heart attack increases. 
• 48 percent of men and 63 percent of women who died suddenly of CVD had no 
previous evidence of disease. 
參 Within 6 years after a heart attack, 23 percent of men and 31 percent of women 
will have another heart attack. 
Heredity 
參 Family history of premature CVD is defined as death of a first degree male 
relative (grandfather, father or brother) or first degree female relative 
(grandmother, mother or sister) before age 65 years. 
1.3.2.2 Modifiable Risk Factors 
Modifiable risk factors for coronary artery disease, those that can be changed, 
include smoking, high blood cholesterol, high blood pressure (hypertension) and 
physical inactivity. 
Smoking 
參 Cigarette smoking is the most important modifiable risk factor for cancer and 
chronic heart disease in the United States. (U.S Surgeon General). It is also the 
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most preventable cause of heart attack as well as a powerful risk factor for sudden 
death, peripheral vascular disease and stroke. 
• Cigarette smoking accelerates the process of arterial thickening or adds the 
equivalent of 10 years of aging to one's arteries, thereby increasing the risk of 
heart attack and stroke. 
• A smoker's risk of heart attack is more than twice that of a nonsmoker's, and 
nearly one-fifth of deaths from CVD are linked to smoking. 
• Evidence indicates that chronic exposure to environmental tobacco smoke 
increases the risk of death due to heart disease by about 30 percent for those 
exposed in their home or at work. 
參 When people stop smoking, their risk rapidly declines so that 3 years after 
quitting a pack per day or less, their risk for heart disease is similar to that of 
non-smokers. 
High Blood Cholesterol 
Cholesterol is a soft, fat-like substance found in all the body's cells. It is produced 
mostly by the liver, and is also found in much food. Cholesterol is necessary to form 
cell membranes, some hormones and other tissues. It is transported in the blood by 
several kinds of lipoproteins. Low density lipoprotein (LDL) or "bad cholesterol", 
along with other substances, can form plaque to clot arteries. High density lipoprotein 
(HDL) or "good cholesterol" is produced mostly in the liver and seems to help protect 
against heart attack. A high level of LDL reflects an increased risk of heart disease, and 
a low level of HDL indicates a greater risk as well. 
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1.3.3 Hypertension 
Blood pressure is the amount of force that blood exerts against the blood vessel 
walls. Systolic pressure represents the contractions of the heart. Diastolic pressure 
represents the heart in its resting phase. Blood pressure is generally considered 
unhealthy if systolic pressure is equal to or above 120mmHg, and/or diastolic pressure 
is equal to or above SOmmHg. (Health Authority of Hong Kong). The one who has 
higher than 160mmHg systolic and 95mmHg diastolic pressure is diagnosed to be 
having hypertension. According to the Health Authority of Hong Kong. The risk of 
heart attack, congestive heart failure, stroke, and kidney failure is increased with high 
blood pressure. 
In order to treat hypertension, scientists keep searching for the vasodilative agents 
(vaso = blood vessel related, dilate = to relax). Nowadays, there are several 
medications that target different tissues or receptors. Here lists some examples: 
Diuretics 
Diuretics are sometimes called "water pills" because they work in the kidney and 
flush excess water and sodium from the body. 
Beta-blockers 
Beta-blockers reduce nerve impulses to the heart and blood vessels. This makes 
the heart beat slower and with less force. Blood pressure drops and the heart works less 
hard. 
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Angiotensin Converting Enzyme Inhibitors 
Angiotensin converting enzyme (ACE) inhibitors prevent the formation of a 
hormone called angiotensin II, which normally causes blood vessels to narrow. The 
ACE inhibitors cause the vessels to relax and blood pressure goes down. 
Angiotensin Antagonists 
Angiotensin antagonists shield blood vessels from angiotensin II. As a result, the 
vessels become wider and blood pressure goes down. 
Calcium Channel Blockers (CCBs) 
CCBs keep calcium from entering the muscle cells of the heart and blood vessels. 
This causes the blood vessels to relax and blood pressure goes down. 
Alpha-blockers 
Alpha-blockers reduce nerve impulses to blood vessels, which allow blood to pass 
more easily, causing the blood pressure to go down. 
Alpha-beta-blockers 
Alpha-beta-blockers work the same way as alpha-blockers but also slow the 
heartbeat, as beta-blockers do. As a result, less blood is pumped through the vessels 
and the blood pressure goes down. 
Nervous System Inhibitors 
Nervous system inhibitors relax blood vessels by controlling nerve impulses. This 
causes the blood vessels to become wider and the blood pressure to go down. 
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Vasodilators 
Vasodilators directly open blood vessels by relaxing the muscle in the vessel walls, 
which cause the blood pressure to go down. 
However, some of them may have side effects. For example, diuretics may cause 
patients' loss of appetite, nausea, vomiting, stomach cramps, diarrhea and dizziness. As 
to beta blockers, patients may feel drowsiness or fatigue, cold hands and feet, 
weakness or dizziness. They might also have dry mouth, eyes, and skin. 
1.3.4 Antioxidant and Ischemia Reperfusion Injury 
Reactive Oxygen Species (ROS) has been implicated in the pathogenesis of many 
diseases including hypertension and atherosclerosis (Dhawan and Jain, 2004). ROS are 
also thought to be involved in the damage of biomembranes during ischemia, 
inflammation and aging (Sekiya et al, 2002). 
Lack of blood supply or ischemia underlies many of the most important 
cardiovascular and cerebrovascular diseases faced by clinicians in their daily practice. 
Many of these ischemic episodes can be reversed at an early stage by surgical or 
pharmacological methods with the ultimate aim of preventing infarction and cell 
necrosis in the ischemic tissues. However, reperfusion of ischemic areas, in particular 
the restoration of oxygen, may contribute to further tissue damage (reperfusion injury). 
For example, the use of thrombolytic therapy in acute myocardial infarction and other 
revascularizations procedures, such as percutaneous transluminal angioplasty and 
coronary artery bypass surgery (also known as PTCA, coronary artery balloon dilation 
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or balloon angioplasty. It is an established, effective therapy for some patients with 
coronary artery disease), may be associated with reperfusion of ischemic myocardium. 
Such ischemia and reperfusion may result in injury to one or more of the biochemical, 
cellular and microvascular components of the heart (Simon et al, 1997). 
Oxidative stress plays a critical role in ischemia-reperfusion injury. Superoxide is 
a major initiator in the free radical cascade and is mainly catalyzed to cytotoxic H2O2 
by superoxide dismutase (SOD) (Peitan et al, 2004). ROS have the potential to directly 
injure cardiomyocytes and vascular cells and may trigger a cascade of inflammatory 
mediators through induction of cytokine expression. Damage induced by ROS on 
intracellular and extracellular targets, such as membrane lipids, proteins, and DNA, 
clearly contributes to myocyte necrosis and / or apoptosis and organ dysfunction during 
myocardial ischemia-reperfusion (IR). Normally, ROS are quickly inactivated by the 
antioxidative system. Therefore, the severity of oxidative tissue injury is determined by 
the balance between ROS production and the intrinsic antioxidative capacity of the 
tissue. 
In the process of ischemia, a severe and sustained reduction in blood flow to the 
myocardium reduces oxidative phosphorylation leading to failure to resynthesize 
energy-rich phosphates including ATP and creatine phosphate. Eventually, the purine 
precursors necessary for resynthesis of ATP are degraded to hypoxanthine and 
xanthine, both substrates for the enzyme xanthine dehydrogenase / oxidase. At the 
same time the enzyme changes conformation from its dehydrogenase form to become 
an oxidase (O form) (Figure. 1.2). During the restoration of oxygen, such as in the 
PTCA surgery, xanthine oxidase metabolizes the oxygen into superoxide. Thus, the 
- 1 6 -
Introduction 
tissue or cells surrounding will be attacked by those by-product. And this injury is 
called ischemia reperfusion injury. 






• S AMP Superoxide -
S I Induced Tissue 
5 Adenosine Injury 
另 暴 • / 
Inosine ^ 
I Xanthine M 
Hypoxanthine ^ .. M 
Oxidase ^ ，• 
O2 � � CV + Urate 
^ Reperfusion • 
Figure 1.2 Ischemia Reperfusion Injury 
If certain drugs possess antioxidative effect, they can prevent the oxidation of 
LDL into modified LDL or oxLDL, and also can remarkably reduce the injury of heart 
tissue during the surgery mentioned. 
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1.4 General Research Objectives: 
According to the process of atherosclerosis and cardiovascular disease, drugs 
possess both antioxidative and vasodilative effects as well as having protective effects 
on ischemia reperfusion injury heart are ideal for curing the disease. Inspired by the 
wisdom of Traditional Chinese Medicine, Danshen and two species of Gegen were 
studying for their cardiovascular tonic effects. 
As there are controversial methods about the classification and functional 
relationship between Yege and Fenge, a comparison between both of them in terms of 
their biological effects was also conducted. The objectives for each parts of this thesis 
are stated as follow: 
A. Vasodilation Study 
1. The vasodilative effects of Fenge, Danshen and compound formula were 
compared. 
2. The endothelium-dependent and Nitric Oxide synthase pathway in vasodilative 
effect of herbal extracts were assessed. 
3. The involvements of alpha! and betai adrenoceptors and the stimulation of the 
potassium channels in vasodilative effects of herbal extracts were studied. 
4. Some active compounds from Fenge and Danshen were tested for their 
vasodilative activity. 
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B. Comparison Between Yege and Fenge for their CardiovascularTonic Effects 
1. The comparison between individual Yege, Fenge and between D:Y (7:3), D:F (7:3) 
for their vasodilative effects were conducted. 
2. The antioxidative activities of Yege, Fenge, D:Y (7:3) and D:F (7:3) were 
compared in the inhibition of AAPH induced RBC hemolysis experiment. 
3. In ischemia reperfusion experiment, Yege, Fenge, D:Y (7:3) and D:F (7:3) were 
investigated for their abilities to reduce leakage of CK and LDH from 
cardiomyocytes, to recover the coronary flow rate and to recover the heart 
contractile force. 
C. Comparison between Ye^e and Fenge for their HPLC chromatographs (Chemical 
profiles) 
1. Standard compounds in Fenge, Yege and Danshen were tested and their HPLC 
chromatographs were prepared. 
2. The HPLC chromatographs of Fenge, Yege, Danshen, and two compound 
formulae were compared and looked for the content difference between them, 
especially between Yege and Fenge. 
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Chapter 2 Establishment of Compound Formulation 
As mentioned, compound formula is more valuable than single herb as synergy 
may occur in certain combinations. In our laboratory, my colleague have established an 
antioxidative test for different combinations of Danshen and Fenge (Fenge is 
commercially available in Hong Kong herbal markets). We used the antioxidative effect 
of compound formula to screen for the best combination of Danshen and Fenge. The 
idea was based on the fact that the attack by free radical to low density lipoprotein is 
the very first step of atherosclerosis. The following information and results related to 
screening of proper ratio of herbs were obtained on my colleague, Ken Leung's M.phil 
thesis (Cardiovascular Tonic Effects of Compound Formula of Radix Salviae 
miltiorrhizae and Radix Puerariae, 2003). 
2.1 Formulation Searched from Chinese Pharmacopoeia 
In order to find out all existing compound formulae, information in "Zhong yao 
fang ji xian dai yan jiu da dian”(Huang and Shi, 1996) was scanned. There are 28 
formulae related to cardiovascular tonic found to consist of both Danshen and Gegen. 
Among them, the most complicated one consists of Danshen, Gegen and 12 other 
TCMs, such as Ginseng, Sanqi, Chuanxiong, while the simplest one consists of only 
three TCMs, Danshen, Gegen and Yanhu. 
Danshen-Gegen-Yanhu tablet is the simplest formula that consists of ground 
Danshen, Gegen and Yanhu in a ratio of 6:3:1 by mass in each tablet (0.6 g). It was 
used to treat coronary heart diseases in human and the dosage was four tablets a time, 
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three times a day for four weeks (孫永智，1986). Yanhu is also called Yanhusuo and 
its Latin name is Rhizoma Corydalis. Recent research shows that Yanhu has 
pharmacological effect, such as analgesic (Hu et al, 1994; Yue, 1981), hypnotic (Buda 
et al” 1984), sedative (Jin et al, 1984), ulceration protection (Soji et al, 1969) and 
muscle relaxation (Zliong et al, 1986). A series of active constituents such as 
^/-corydaline, JZ-terahydropalmatine, protpine, corydalis L were identified. 
The antioxidative test was in terms of inhibition against 
2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH) induced red blood cell 
hemolysis. AAPH generates free radical to attack the membrane of red blood cells and 
eventually lead to hemolysis. The stronger antioxidative effect of the drug, its 
percentage of inhibition against red blood cell hemolysis, would be higher. 
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Figure 2.1. Screening of compound formula, data obtained from our laboratory. 
Percentage inhibition of the 3 individual formulae, Danshen (DS), Gegen (FG) and 
Yanhu 元胡（Y) and the 4 compound formulae, 6:3:1 (D:G:Y)，7:3 (D:G)，2:1 (D:G) 
and 1:1 (D:G). IC50 were 141 ^g/ml, undetectable, undetectable, 180 贈ml, 168 
昭/ml，198 jig/ml and 282 fig/ml, respectively. Curves are plotted by mean of n=7. 
When the ratio of Danshen，Fenge and Yanhu was 6:3:1 and the ratio of Danshen 
and Fenge was 7:3，they showed the greatest antioxidative effect. Yanhu was shown to 
have analgesic effect (alleviates pain without causing loss of consciousness) (Chinese 
Pharmacopoeia, 1995 edition). It was eliminated from the original formula, for the 
reason that patient's life would be threatened if he or she felt no pain in angina 
pectoris or heart attack. Therefore, the formula in which Danshen and Fenge ratio is in 
7:3 was chosen to be the best combination between two herbs according to their 
antioxidative effect, and this compound formula was used in the following 
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experiments. 
From the result, individual Danshen showed the lowest IC50 amount all the 
samples tested. However, the compound formula was chosen based on the rationale of 
Chinese medicine: Danshen may perform very well in terms of antioxidative effect 
but we should consider the benefit of the drug to whole-body. Therefore, compound 
formulae were the focus of this screening experiment. 
-24 -
i Establishment of Compound Formula 
2.2 Aqueous Extract Preparation 
Aqueous (water) extract was studied in this project because it was commonly 
used in traditional medicines and dietary supplements. The powder form of aqueous 
extracts of the compound formula with Danshen, Fenge and those individual herbal 
extracts were prepared. 
2.2.1 Materials and methods 
Raw materials 
Danshen was supplied by New World China Enterprises Projects Limited and the 
Danshen was grown at Sichuan province in compliance with Good Agriculture 
Practice (GAP). Fenge was purchased from a local herbal company in Hong Kong. 
Fenge was grown at Guangxi province, also in compliance with GAP. All of them 
were authenticated by ICM, CUHK. Herbs were cut into small pieces before 
extraction, Danshen was cut into pieces of size 2 x 1 x 1 cm, while Fenge was cut into 
pieces about 3 x 3 x 0.5 cm pieces and Yanhu was cut into 1 x 1 x 0.5 cm pieces. 
Herb Voucher specimen no. of ICM Museum 
Danshen 2004-2512 
Fenge 2003-2485 
^ ^ 2003-2484 
Table 2.1. The herbal materials used in this project and their voucher specimen 
numbers. 
ICM: Institute of Chinese Medicine, The Chinese University of Hong Kong 
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Reflux extraction 
Appropriate amount of the raw materials were weighed and then gently rinsed 
with distilled water. Raw materials were refluxed with distilled water in 1:10 (weight 
(lOOg) to volume (IL) for 1 hour on a heating mantle. The time was started from the 
time after the water boiled. After one hour reflux, the decoction was cooled down and 
collected. Next, extra 1:10 distilled water was added to the raw materials to reflux for 
one more hour. Similarly, decoction was collected then followed by half an hour of 
boiling. The decoction was kept in a 4�C refrigerator overnight for further steps. 
Filtration 
Cold decoction was divided into several 450ml-centrifuge bottles and then 
centrifuged at 7,700 x g for 20 minutes. Supernatant was collected and filtered with 
filter paper under suction to filter out all the insoluble particles. 
Lyophilization 
Clear decoction was divided into lyophilize bottles, up to 300 ml each bottle. 
Bottles were frozen under liquid nitrogen and the frozen decoction was kept no more 
than 1.5 cm thick surrounding the inner side of the bottle. The bottles were dried on 
lyophilizer under vacuum for 3-4 days until dry powder appeared in the bottle. 
Powder extract was collected into falcon tubes and kept in a desiccator (preserved in 
dry environment) at room temperature. 
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Raw materials (g) Powder extract (g) Percentage yield (%) 
Danshen (DS) 50 27 54 
Fenge (FG) 50 7 14 
Yege (YG) 100 54.86 54.86 
D:F (7:3) 100 40.5 40.5 
D:Y (7:3) 150 82.87 55.25 
Table 2.2. The percentage yields in powder preparation of the raw herbal materials. 
2.2.2 Discussion 
The extracts of compound formulae were prepared by mixing TCMs before 
decoction. In this way, the content of compound formula extract may differ from that 
of individual Danshen and Fenge / Yege, which means that the pharmacological effect 
of extract will be altered. Moreover, during heating of the mixture, new compounds 
may even appear. Both of the possibilities may lead to a synergistic effect of 




Chapter 3 Vasodilation Study 
3.1 Vascular Smooth Muscle Contraction and Relaxation 
The contractile characteristics and the mechanisms that cause contraction of 
vascular smooth muscle (VSM) are very different from cardiac muscle. VSM 
undergoes slow, sustained, tonic contractions, whereas cardiac muscle contractions are 
rapid and of relatively short duration. While VSM contains actin and myosin, it does 
not have the regulatory protein troponin that is found in the heart cells. Furthermore, 
the arrangement of actin and myosin in VSM is not as well-organized as that of cardiac 
muscle. 
Contraction in VSM can be initiated by mechanical, electrical, and chemical 
stimulations. Passive stretching of VSM can cause contraction that originates from 
the smooth muscle itself. Electrical depolarization of the VSM cell membrane also 
elicits contraction, most likely by opening voltage dependent calcium channels (L-type 
calcium channels) and causing an increase in the intracellular concentration of 
calcium. Finally, a number of chemical stimuli such as norepinephrine, vasopressin, 
endothelin-1, and thromboxane A2 can cause contraction. Each of these substances 
bind to specific receptors on the VSM cell or that of endothelial layer adjacent to the 
VSM, which then leads to VSM contraction. The mechanism of contraction involves 
different signal transduction pathways. However, all of them are resulted from 
increasing intracellular calcium. 
Intracellular calcium concentrations are very important in regulating smooth 
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muscle contraction. The concentration of intracellular calcium depends upon the 
balance between the calcium entering the cells, the calcium that is released by 
intracellular storage sites such as sarcoplasmic reticulum (SR), and removal of calcium 
either back into storage sites or out of the cell. Calcium is re-sequestered by the SR 
by a ATP-dependent calcium pump. Calcium is removed from the cell to the external 
environment by either a ATP-dependent calcium pump or by the sodium-calcium 
exchanger. 
There are several signal transduction mechanisms that modulate intracellular 
calcium concentration and therefore the state of vascular tone. 
1) phosphatidylinositol pathway, 
2) Gs-protein-coupled pathway 
3) nitric oxide-cGMP pathway. 
For the second one, the Gs-protein coupled pathway stimulates adenylyl cyclase 
(AC) that catalyzes the formation of cAMR In VSM, an increase in cAMP stimulated 
by a betai-adrenoceptor agonist such as epinephrine or isoproterenol causes 
relaxation. The mechanism for this is cAMP inhibition of myosin light chain 
kinase. Therefore, increased cAMP decreases myosin light chain phosphorylation, 
which decreases the interactions between actin and myosin. Therefore, drugs which 
increase cAMP like phosphodiesterase inhibitors can, theoretically, cause vasodilation. 
A third mechanism that is very important in regulating VSM tone is the nitric 
oxide (NO)-cGMP system. Briefly, increase in NO activate guanylyl cyclase causes 
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increased formation of cGMP and vasodilation. The precise mechanisms by which 
cGMP relaxes VSM is unclear; however, cGMP can activate a cGMP-dependent 
protein kinase, inhibit calcium entry into the VSM, activate potassium channels, and 
decrease inositol triphosphate. 
3.2 Endothelium and Vasodilation 
In the last 20 years, the endothelium has been considered as a complex organ 
system that controls vascular homeostasis by integrating signals between the vascular 
wall and the vessel lumen. Today, it is widely accepted that the endothelium plays 
important roles in maintaining a normal vascular tone and blood fluidity, reducing 
platelet activity and leukocyte adhesion, and limiting vascular inflammatory reactions 
(Gimbrone, 1995). Under normal conditions, it regulates vascular homeostasis by 
elaborating a variety of factors that act locally in the blood vessel wall and lumen, such 
as nitric oxide (NO), prostacyclin and endothelin. However, in particular situations the 
endothelium can also modify its phenotype in order to facilitate vasoconstriction, 
inflammation, and thrombotic events. These abnormal responses manifest with 
conditions, such as hypercholesterolemia, hypertension, diabetes mellitus, and occur in 
the absence of any morphological change of the vessel (Drexler, 1997). Interestingly, 
consistent evidence suggests that they are precursors of atherosclerosis and predictors 
of future vascular events (Halcox et al, 2002). The etiology of these altered endothelial 
functions is multi-factorial, and the mechanisms underlying them are complex and not 
yet fully elucidated. Among these factors, altered receptor signaling due to membrane 
changes, alterations of endothelium nitric oxide synthase (eNOS) expression and 
activity and increased generation of superoxide radicals, all have been considered 
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responsible for these alterations (Gokce et al, 1998). 
The endothelium also plays an important role in regulating vascular tone by 
releasing several vasoactive autacoids including prostacyclin (Vane et al, 1990)， 
endothelium-derived relaxing factor (EDRF) (Furchgott and Zawadzki, 1980) and 
endothelium-derived hyperpolarizing factor (EDHF) (Feletou and Vanhoutte, 1988). 
EDRF has been identified as nitric oxide (NO), which is produced from L-arginine by 
• • 21 
the binding of Ca -calmodulin to nitric oxide synthase (Ignarro et al, 1987: Palmer et 
a/，1987). NO relaxes blood vessels mostly by stimulating soluble guanylyl cyclase 
(sGC)，which leads to an increased production of cGMP in vascular smooth muscle 
(Rapoport and Murad, 1983). 
In the earlier part of my study, the vasodilative effects of the herbal extracts 
would be tested (section 3.3). The involvement of the roles of endothelium and related 
enzymes would also be focused (section 3.4). 
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3.3 Vasodilation in organ bath 
Organ bath experiment using thoracic aorta was well-known for studying the 
vasodilative effect of drugs. By addition of the different extracts, the changes of 
isometric tensions of pre-contracted aorta rings can directly reflect the vasodilative 
function of the extracts to aorta rings. 
The vasodilative effect of D:F (7:3) compound formula, Danshen aqueous and 
Fenge aqueous extracts were investigated by the ex-vivo organ bath setup. 
3.3.1 Materials and Methods 
Chemicals 
(R)-(-)-phenyleplirine hydrochloride (Phe), acetylcholine chloride (Ach) and 
9,11 -dideoxy-9a, 11 a-epoxymethano prostaglandin F2a (U46619) were purchased from 
Sigma. Krebs solution (118.0 mM NaCl, 4.7 mM KCl, 1.64 mM MgS04, 1.2 mM 
KH2PO4, 5.55 mM D-glucose, 25.0 mM NaHCOs and 2.5 mM CaCy was adjusted to 
pH 7.4 and filtered. 
Amimal 
Aorta was removed from adult male Sprague-Dawley (SD) rats (-300 g body 
weight, killed by cervical dislocation) and placed in a physiological saline solution 
(Krebs solution). After fat and connective tissue were removed, aorta was cut into 1.5 
mm width rings. The isolated aorta rings were mounted between wire hooks in organ 
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bath. The condition was maintained at 37°C Krebs solution and was gassed with 
mixture of 95% O2 and 5% CO2. The rings were equilibrated for 1 hour (change Kerbs 
solution every 20 minutes) under a resting tension of 2.5 g, which always 
re-establishes after washing out the subsequently administered drugs (baseline tension 
were corrected by adjusting the passive stretch). 
Pre-test 
The integrity of the aorta rings was verified by a pre-test. Rings were first 
contracted with 0.3 jiM phenylephrine for 15 minutes and then relaxed with 0.3 ^M 
acetylcholine. Since acetylcholine is a endothelial-dependent relaxation agent, if 80% 
or more relaxation was shown when comparing to the 0.3 [iM phenylephrine-induced 
contraction, the aorta ring was defined to have a intact endothelium layer and thus 
could be used for further drug tests. Aorta ring was then equilibrated for an hour with 
three times washing with Krebs solution before drug test. 
Drug test 
The aorta rings were contracted by 15 nM U46619, which is a potent 
prostaglandin H2 receptor agonist, for 20 minutes. Herbal extracts were then added to 
the organ bath and the isometric tension was monitored with a transducer throughout 
the experiment. Herbal extracts were prepared by Krebs solution. 
To dissolve the herbal extracts with Krebs solution 
For compound formula and Danshen extract, the powder prepared (mentioned in 
chapter 2) was dissolved in Krebs solution at 500 mg/ml as the stock. Fenge extract, 




Tensions were recorded by MacLab data acquisition system through Grass 
force-displacement transducers, FT-03E. Data was recorded by a sampling rate of 10 
per second. Finally, results were expressed as percentage relaxation response of the 
maximal contraction induced by 15 nM U46619. 
Statistical Analysis 
Values are mean 士 SD. Statistical assessments of the data were made by Student's 
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Figure 3.1. Effects of compound formula on aorta were investigated. Screenshot of the 
MacLab system showing the dose response vasodilation of the D:F (7:3) aqueous 
extract. Vertical dimension represents the isometric tension force of the aorta ring in 
the unit of gram (g) and the horizontal dimension represents the time course during 
experiment. Control, formula concentrations 1 mg/ml, 2 mg/ml, 3 mg/ml, 4 mg/ml and 
10 mg/ml were respectively added in channel 1 to 6. 
This result showed that when the concentration of compound formula increased, 
the time for aorta to relax (tension decrease) was shorter. Dose dependent manner can 
be clearly observed. 
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Figure 3.2. Dose-dependent vasodilative effect of D:F (7:3) compound formula. In 
each case，the relaxation is the response the response the response of 
U46619-mduced tone. The relaxation Data are shown as mean 土 SD (n==6). 
The effects of all doses of compound formulae were significantly different from 
that of control at around 45 min. The effects were also getting stronger when the dose 
increased (P value not shown). 
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Figure 3.3. The comparison of the vasodilative effects of Danshen (DS), Fenge (FG) 
and compound formula. They were all in 4 mg/ml. The relaxation is the response of 
U46619-induced tone. Data are shown as mean 士 SD (n=5). *F<0.05 DS-treated / FG 
treated versus D:F (7:3)-treated sample. *尸<0.05 DS-treated versus FG-treated sample. 
The effect of compound formula was significantly different from that of 
individual DS and FG at around 45 min. The order of effectiveness were compound 
formula D:F (7:3) > Danshen > Fenge (all are statistic significant). 
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Figure 3.4. The synergistic effect of compound formula. The compound formula D:F(7:3) 
used was 4 mg/ml. Ratio of DS and FG were 2.8 mg/ml (4x 70%) and 1.2 mg/ml (4x 
30%), respectively. The summation of the vasodilative effects of DS and FG were 
represented as closed square. The relaxation the response of U46619-induced tone. Data 
are shown as mean 士 SD (n=5). 
4 mg/ml compound formula consisted of 70 % Danshen (4x 70%) = 2.8 mg/ml, 
and 30 % Fenge (4x 30%) = 1.2 mg/ml. The latter one was no effect in such low 
concentration. The summation of their vasodilative effects would be theoretically equal 
to that of compound formula. However, the effect of compound formula was greater 
than that of the calculated one and elicited a synergistic effect on vasorelaxation. 
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In fig 3.2，the higher of concentration of compound formula used, the faster (less 
time consumed) aorta ring reached 50 % relaxation，compared to U46619-tone. It 
demonstrated the dose-dependent response of the compound formula. Fig 3.3 showed 
that in the same concentrations of Fenge, Danshen and compound formula, the order of 
effectiveness were compound formula D:F (7:3) > Danshen > Fenge. (*P<0.05 DS / 
FG versus D:F (7:3)-treated sample. *户<0.05 DS-treated versus FG-treated sample.) 
Obviously, the compound formula was superior to that of individual herbs. However, 
in order to work out the possibility of synergy of compound formula, the 
corresponding concentrations of Fenge and Danshen were tested. Theoretically, 4 
mg/ml compound formula consisted of 70 % Danshen (4x70%) = 2.8 mg/ml, and 30 % 
Fenge (4x30%) = 1.2 mg/ml. The summation of their vasodilative effects would be 
equal to that of compound formula. Interestingly, the effect of compound formula was 
greater than that of the calculated one and elicited a synergistic effect on 




The result is consistent with the main theory of traditional Chinese medicine 
(Chinese Herbal Medicine, 1987), which always emphasizes the interaction between 
different herbal materials and that one should prepare different formula for each clinical 
case. In the previous screening process of my colleague, Ken Leung, he prepared 
formulae containing different ratios of Danshen and Fenge and tested for their 
antioxidative function (Cardiovascular Tonic Effects of Compound Formula of Radix 
Salviae miltiorrhizae and Radix Puerariae, 2003). 
• The different results might be caused by different interactions in different 
combinations, which highlight the importance of further research in the investigation 
and the use of compound formula as opposed to the use of just one herb. 
In summary, the compound formula showed a dose-dependent as well as a 
synergistic vasodilative effect, which give the value to the investigation and the use of 
compound formula. 
3.4 Endothelium Dependent Vasodilation 
Vasodilators (such as acetylcholine, which is the typical endothelial 
NO-dependent vasodilator) triggers the increase of intracellular calcium level in the 
endothelial cells. The elevation of intracellular calcium concentration activates the 
endothelial Nitric Oxide synthase (eNOS). eNOS is responsible for a continual 
production and release of NO by endothelial cells, using amino acid L-arginine and 
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molecular oxygen as sources. NO will then diffuse into smooth muscle cells, where it 
activates soluble guanylyl cyclase (sGC)，an enzyme catalyzes conversion of CTP into 
cyclic CMP. Cyclic GMP then activates cyclic GMP-dependent protein kinase (PKC). 
It acts on several intracellular targets to lower intracellular calcium in vascular smooth 
muscle. They include activation of potassium channels and plasma membrane calcium 
ATPase, in order to increase the removal of calcium from the cells. The calcium influx 
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Figure 3.5. Endothelium-derived Vasodilator: It is the simplified intracellular signaling 
pathways that mediate the vasorelaxation. 
Some research studies have shown that many cardiovascular diseases are 
associated with an impaired function of endothelium and reduced production of its 
product Nitric oxide (NO), which is an important vasodilative agent (Feletou and 
Vanhoutte, 1988). In order to investigate the mechanism and the role of endothelium 
involved in vasodilative effect of compound formula, Danshen and Gegen, these herbal 
extracts were tested by aorta rings after the removal of endothelium. Next, eNOs 
inhibitor L-nitro-arginine methyl ester (L-NAME) and sGC inhibitor 
1 H-( 1,2,4)-oxadiazolo (4,2-a) quinoxalin-l-one (ODQ) were added into an organ bath 
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prior to the contraction of intact aorta rings so as to study the involvement of NO in 
herb-treated vasodilation. 
Beside NO, endothelium is also involved in vasodilation via Prostacyclin. (Zhou 
et al, 2005) Prostacyclin is synthesized from arachidonic acid by cyclooxygenase 
(COX) and is released from the endothelium. It promotes vasodilation by increasing 
smooth muscle cell cyclic AMP levels via interaction with the Gs-protein-coupled 
receptor. Cyclic AMP activates cyclic AMP dependent protein kinase (PKA). One of 
the primary functions of PKA is to promote opening of the potassium channel leading 
to membrane hyperpolarization and the resultant inhibition of calcium influx through 
voltage-gated calcium channels. Indomethacin is an inhibitor of COX and thus blocks 
the vascular action of prostacyclin. 
3.4.1 Materials and Methods 
The same as section 3.3.1，with the following amendments and procedure added: 
Removal of endothelial layer 
The endothelium was removed by using forceps and gently rubbing the intimal 
surface of the aorta on the hand with a clean glove. The glove was pre-moistened with 
Krebs solution before handling the aorta rings. 
Drug test 
The aorta rings were contracted prior to the addition of different herbal extracts by 
adding 15 nM U46619 to the organ bath, which is a potent prostaglandin H2 receptor 
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agonist. In the study of effects of inhibitors, lOOjiM L-NAME, l|iM ODQ and l|iM 
indomethacin were incubated for 30 minutes prior to the addition of U46619. In 
order to obtain similar initial tensions induced by U46619 in all experiments, 
concentrations of U46619 were adjusted in the presence of L-NAME, ODQ and when 
the endothelium of the aorta rings were removed. For L-NAME, the concentration of 
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Figure 3.6. Endothelium dependent vasodilation of 4 mg/ml compound formula. (wE) 
represents with endothelium, (woE) represents without endothelium. The relaxation is 
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Figure 3.7. Effect of L-NAME, an inhibitor of NO synthase, on 4 mg/ml compound 
formula in intact endothelium aortic rings of rats. The aortic rings were incubated 
with lOOjiM L-NAME 30 min before contraction by 15 nM U46619. The relaxation 
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Figure 3.8. Endothelium dependent vasodilation of 4 mg/ml Fenge. (wE) represents 
with endothelium, (woE) represents without endothelium. The relaxation is the 
response of U46619-induced tone. The relaxation data are shown as mean 士 SD (n=5). 
*P<0.05 woE versus wE FG-treated control. 
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Figure 3.9. Effect of L - N A M E , an inhibitor of N O synthase, on 4mg/ml Fenge on 
intact endothelium aortic rings of rats. The aortic rings were incubated with lOOjuM 
L - N A M E 30 min before contraction by 15 n M U46619. The relaxation is the response 
of U46619-induced tone. The relaxation data are shown as mean 士 S D (n=5). *P<0.05 
versus FG-treated control. 
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Figure 3.10. Effect of ODQ, an inhibitor of soluble guanylyl cyclase (sGC), on 4 
mg/ml Fenge in intact endothelium aortic rings of rats. The aortic rings were incubated 
with l[iM ODQ 30 min before contraction by 10 nM U46619. The relaxation is the 
response of U46619-induced tone. The relaxation data are shown as mean 士 SD (n=5). 
*P<0.05 versus FG-treated control. 
To compare the inhibitory effects of L-NAME and ODQ, the latter seemed not to 
block the function of Fenge as efficient as that of L-NAME. In the nitric oxide pathway, 
ODQ inhibits the activity of sGC, which is behind NO synthase (Fig. 3.5) (inhibited by 
L-NAME). In the experiment using ODQ, Endothelium can still produce NO but they 
cannot be utilized by sGC. The NO synthase pathway will then stop. However, sGC is 
not the sole downstream target of NO. NO can also directly activate Ca^^-dependent 
K+ channels (K+Ca channel), activation of this potassium channel can eventually 
contribute to the relaxation of SMC. 
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Figure 3.11. Effect of indomethacin (indo), an inhibitor of cyclooxygenase, on 
4mg/ml Fenge in intact endothelium aortic rings of rats. The aortic rings were 
incubated with l|aM indomethacin 30 min before contraction by 15 nM U46619. 
The relaxation is the response of U46619-induced tone. The relaxation data are 
shown as mean 士 SD (n=5). 
The function of herbal extract was not inhibited by indomethacin, its vasodilative 
effect was, on the contrary, even stronger than without indomethacin (although the 




C. Danshen Aqueous Extract 
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Figure 3.12. Endothelium dependent vasodilation of 4 mg/ml Danshen. (wE) 
represents with endothelium, (woE) represents without endothelium. The relaxation is 
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Figure 3.13. Effect of L-NAME, an inhibitor of NO synthase, on 4 mg/ml Danshen 
in intact endothelium aortic rings of rats. The aortic rings were incubated with 
lOOjiM L-NAME 30 min before contraction by 15 nM U46619. The relaxation is 
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Figure 3.14. Effect of indomethacin, an inhibitor of cyclooxygenase, on 4 mg/ml 
Danshen in intact endothelium aortic rings of rats. The aortic rings were incubated with 
\[iM indo 30 min before contraction by 15 nM U46619. The relaxation is the response 
of U46619-induced tone. The relaxation data are shown as mean 士 SD (n=5). 
In the presence of indomethacin, the function of Danshen was not decrease but 
even stronger (with significant). The effect of indomethacin and cyclooxygenase will 




In this results part, the roles of endothelial cells in vasodilative effect of herbal 
extracts were assessed. In Fig 3.6 and Fig 3.7, the effects of compound formula were 
no different in the presence of L-NAME and with the removal of endothelium. This 
implied that the effect of compound formula was endothelium-independent. However, 
does it mean that the individual Fenge and Danshen herbal extracts have similar 
properties? Fenge and Danshen were then studied separately. For Fenge, it is observed 
that its effect was significantly decreased when the endothelial layer was removed 
from aorta rings (Fig 3.8). For the reason that endothelium plays different roles in the 
vasodilation, we have tried to figure out which pathway(s) related to endothelium were 
involved. L-NAME, ODQ and indomethacin, the inhibitors of nitric oxide synthase, 
soluble guanlyly cyclase and cyclooxygenase, respectively, were used. In Fig 3.9 and 
Fig 3.10, two enzyme inhibitors related to NO-mediated pathway caused the 
attenuation effects of Fenge, while that of indomethacin was not affected. It suggested 
that the vasodilative function of Fenge was mediated by NO synthase pathway but not 
cyclooxygenase-related (Fig 3.11). 
For the effect of Danshen, its function was not decreased by the removal of 
endothelium, pre-incubated with L-NAME and indomethacin (Fig 3.12 - Fig 3.14). 
Therefore, the involvement of endothelium of vasodilative effect of Danshen could be 
ruled out accordingly. 
For the effect of indomethacin, in both tests for Danshen and Fenge, this 
'inhibitor' led to the stronger vasodilative effect for herbal extracts. To explain this 
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phenomenon, the isoforms of cyclooxygenase (COX) should be introduced. COXl and 
C0X2 are isozymes of COX. They mediate the enzymatic conversion of arachidonate 
to prostaglandin H2 (PGH2) and many different kinds of other prostaglandin 
metabolites (Zhonghua et al, 2002). Some prostaglandins are related to 
vasoconstrictoion likes TxA�，while some are vasodilator such as PGI2. COXl and 
C0X2 exhibit similar biochemical activity in converting arachidonate to PGH2, but the 
ultimate prostanoids they produce in vivo may be different due to differential 
regulation of COXl and C0X2 and the availability of the downstream prostanoid 
synthases. C0X2 is playing the role of vasodepressor (vasodilation), while 
COXl-derived products help balancing the effect of C0X2 by mediating the 
vasoconstrictor action (Zhonghua et al, 2002). Indomethacin inhibits both COXl and 
C0X2. The extracts did not inactivate C0X2 (the vasodilative effect was not 
attenuated). However, the blocking effect of indomethacin for COXl led to the further 
relaxation of aorta rings. 
3.5 Adrenoceptors and Vasodilation 
Alp ha 2- adrenoceptor blocker 
The alpha�- adrenoceptors are widely distributed in the cardiovascular system and 
they are functionally expressed in the endothelial cells. Whereas activation of 
pre-synaptic alpha�- adrenoceptors decreases sympathetic activity, activation of smooth 
muscle alpha!- adrenoceptors classically inhibits the activity of adenylyl-cyclase 
pathway leading to smooth muscle contraction (Limbird, 1998; Nebigil and Malik, 
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1992). According to Kim et al (1999), alpha!- adrenoceptor antagonists enhance the 
production of NO via NO synthase in the endothelium. Therefore, vasodilative effects 
of herbal extracts were studied for their involvement of the action of alpha?-
adrenoceptors. In the following experiments, l|iM yohimbine, which is the alphai-
adrenoceptor antagonist, was used to pre-incubate in organ bath prior to contraction of 
aortic ring. 
Beta I- adrenoceptor blocker 
For over two decades, blockers of beta adrenergic receptors, calcium antagonists, 
diuretics, vasodilators, and inhibitors of angiotensin-converting enzyme (ACE) are 
being used in the treatment of hypertensive patients (Mercedes Villarroya et al, 1999). 
Hypertension (high blood pressure) may be treated with beta blocker because of 
their ability to increase the diameter of the blood vessels thus allowing blood to flow 
under less pressure. Beta blockers are competitive inhibitors and interfere with the 
action of stimulating hormones on beta-adrenergic receptors in the nervous system. 
Beta blockers can be subdivided into two distinct groups, known as betai and beta�. 
Most beta blockers are non specific, meaning that they have both betai and beta� 
effects. Atenolol is a betai blocker. In the following experiment, lOjiM atenolol was 




3.5.1 Materials and Methods 
The same as section 3.3.1’ with the following amendments and procedure added: 
Chemicals 
Yohimbine hydrochloride and Atenolol were purchased from sigma. 
Drug test 
The aortic rings were contracted prior to the addition of different herbal extracts 
by adding 15 nM U46619 to the organ bath. In order to study the role of adrenoceptor 
to vasodilative effect of herbal extracts, l^iM Yohimbine and lOijM Atenolol were 
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Figure 3.15. Effect of atenolol, a betai-adrenoceptor blocker, on 4 mg/ml Fenge 
aqueous extract in intact endothelium aortic rings of rats. The aortic rings were 
incubated with lOjiM atenolol 30 min before contraction by 15 nM U46619. The 
relaxation is the response of U46619-induced tone. The relaxation data are shown as 
mean 士 SD (n=5). 
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Figure 3.16. Effect of yohimbine (yoh), a alphai-adrenoceptor, on 4 mg/ml Fenge 
aqueous extract in intact endothelium aortic rings of rats. The aortic rings were 
incubated with l)uM yohimbine 30 min before contraction by 15 nM U46619. The 
relaxation is the response of U46619-induced tone. The relaxation data are shown as 
mean 士 SD (n=5). 
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Figure 3.17. Effect of atenolol on 4 mg/ml, a betai-adrenoceptor blocker, Danshen 
aqueous extract in intact endothelium aortic rings of rats. The aortic rings were 
incubated with lO i^M atenolol 30 min before contraction by 15 nM U46619. The 
relaxation is the response of U46619-induced tone. The relaxation data are shown as 
mean 士 SD (n=5). 
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Figure 3.18. Effect of yohimbine (yoh), an alphai-adrenoceptor blocker, on 4 mg/ml 
Danshen aqueous extract in intact endothelium aortic rings of rats. The aortic rings 
were incubated with l^M yohimbine 30 min before contraction by 15 nM U46619. 
The relaxation is the response of U46619-induced tone. The relaxation data are shown 




In Fig 3.15 - Fig 3.18, both atenolol and yohimbine failed to affect the 
vasodilative functions of Fenge and Danshen. Therefore, the involvements of alpha! 
and betai adrenocepters could be excluded as a reason for the vasodilative effects of 
two herbal extracts. 
However, it was only a glance of the role of adrenoceptors for the effect of two 
herbs. Many adrenoceptors might still have opportunity to play a role in the relaxing 
effect of Fenge and Danshen. 
-62 -
Vasodilation Study 
3.6 Potassium Channels and Vasodilation 
Potassium Channels and Vasodilation 
Although Fenge was showed to have vasodilative effect mediated by NO synthase 
pathway, the inhibitory effects of L-NAME and ODQ could not totally block the effect 
of herbs. This suggested that the effect of herbal extracts could be multifactorial. 
Therefore, it was necessary for further investigation to be carried out. 
Nitric oxide is the major endothelium-derived relaxing factor (EDRF).It is 
thought to relax smooth muscle cells by stimulation of guanylyl cyclase, accumulation 
of its product cyclic GMP, and cGMP-dependent modification of several intracellular 
processe, including activation of potassium channels through cGMP-dependent 
protein kinase. Evidence showed that both exogenous nitric oxide and native EDRF 
can directly activate single Ca(2+)-dependent K+ channels (K+Ca) in cell-free 
membrane patches without requiring c G M P . (Bolotina et al, 1994). Since potassium 
channels are major determinants of membrane potential and vascular tone (Nelson and 
Quayle, 1995), changes in potassium channel activity m a y alter the calcium 
mobilization subsequently to result in vasodilation. It is reasonable to suppose that 
activation of potassium channels could result from the exposure to drugs that 
elevate the NO level. 
The activation of potassium channels results in smooth muscle cells 
hyperpolarization, which in turn decrease the intracellular concentration of calcium. 
Smooth muscle cells relax eventually. 
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Figure. 3.19. The relaxation response of arterial smooth muscle cells to the 
opening of potassium channels and closing of voltage-gated calcium channel. 
In some experiments, in order to investigate the possible involvement of 
potassium channels in vasodilation in response to drug samples, 60mM KCl (high 
concentration of potassium in Kerbs solution) was used to induce tension by 
substituting equimolar concentration of NaCl with KCl (McCulloch et al, 1997). In 
order to specifically characterize which kind of potassium channel was being activated 
by drug samples, inhibitors for specific potassium channels were pre-incubated prior to 
the addition of U46619 of aorta rings. The following table showed some common 
targets and their corresponding blockers. 
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Potassium Channels Blockers 
Voltage-dependent K^ Channel (K^^ 4-aminopyridine 
Large-conductance Charybdotoxin 
Ca2+ -activated TT Channel (LK^J 
Small-conductance Apamin 
Ca2+ -activated IT Channel (SK^J 
Inward Rectifier K+ Channel (Kj^ Barium Chloride 
Non-selective Ca^^ -activated K^ Tetraethylammonium 
Channel 
A TP-sensitive Channel (K^ jp) Glibenclamide 
Table 3.1. Examples of commonly used potassium channel blockers 
3.6.1 Materials and Methods 
The same as section 3.3.1’ with the following amendments and procedure added: 
Chemicals 
(R)-(-)-phenylephrine hydrochloride (Phe), acetylcholine chloride (Ach), 9,11-
dideoxy-9a, 11 a-epoxymethano prostaglandin Fia (U46619), 4-aminopyridine (4-AP), 
Barium chloride (BaCli) and Tetraethylammonium (Tea) were purchased from sigma. 
Krebs solution (118.0 mM NaCl, 4.7 mM KCl, 1.64 mM MgS04, 1.2 mM KH2PO4, 




High potassium Krebs solution 
In experiments with a high concentration of potassium, an isotonic 60 mmol/L 
KCl krebs solution was prepared by equimolar replacement of NaCl with KCl. 
Drug test 
The aortic rings were contracted prior to the addition of different herbal extracts 
by adding 15 nM U46619 to the organ bath. In the study of effects of potassium 
blockers, 3mM 4-aminopyridine (4-AP), 0.3mM Barium chloride (BaCy and lOmM 
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Figure. 3.20. Vasodilative effect of 4 mg/ml Fenge aqueous extract on the 
vasoconstriction induced by 60mM KCl (high K) and by 15 nM U46619 (U4). The 
relaxation is of 60mM KCl and the response of U46619-induced tone. The 
relaxation data are shown as mean 士 SD (n=5). *P<0.05 versus U46619-induced 
control. 
The function of Fenge was abolished when aorta rings were pre-contracted by 
high concentration of potassium. In the presence of excess potassium, all the potassium 
channels on smooth muscle cell membrane were closed in order to maintain the 
membrane potential. This action interfered the vasodilative effect of Fenge, which 
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Figure 3.21. Effect of Tetraethylammonium (Tea), a non-selective calcium-activated 
K+ channel blocker, on 4 mg/ml Fenge aqueous extract-induced vasodilation. The 
aortic rings were incubated with lOmM Tea 30 min before contraction by 15 nM 
U46619. The relaxation is the response of U46619-induced tone. The relaxation data 
are shown as mean 士 SD (n=5). *尸<0.05 versus FG-treated, without Tea control. 
Tetraethylammonium is a non-selective calcium-activated K+ channel blocker. The 
inhibitory effect of it on the vasodilative effect of herbal extract was not as completed 
as experiment using high potassium. It is revealed by the result that the function of 
Fenge was not completely abolished. 
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Figure. 3.22. Effect of Barium Chloride ((BaCl�)，an inward rectifier K+ channel 
blocker, on 4 mg/ml Fenge aqueous extract-induced vasodilation. The aortic rings 
were incubated with 0.3mM BaCl�30 min before contraction by 15 nM U46619. 
The relaxation is the response of U46619-induced tone. The relaxation data are 
shown as mean 士 SD (n=5). *尸<0.05 versus FG-treated, without BaCl] control. 
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Figure. 3.23. Effect of 4-aminopyridine (4-AP), a voltage-dependent K+ channel 
blocker, on 4 mg/ml Fenge aqueous extract-induced vasodilation. The aortic rings 
were incubated with 3mM 4-AP 30 min before contraction by 15 nM U46619. The 
relaxation is the response of U46619-induced tone. The relaxation data are shown as 
mean 士 SD (n=5). *P<0.05 versus FG-treated, without 4-AP control. 
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Agent Pharmacological action Inhibitory 
effect to 
Fenge (Y/N) 
L-NAME Inhibition of nitric oxide synthase Y 
ODQ Inhibition of soluble guanylate cyclase Y 
Indomethacin (Indo) Inhibition of cyclooxygenase N 
High K+ contraction Closed all the K+ channels Y 
Tetraethylammonium 
Inhibition of non-selective K+ channel Y 
(Tea) 
4-aminopyridine Inhibition of voltage-sensitive K+ (Ky) 
(4-AP) channels 
Barium chloride Inhibition of voltage-dependent inward 
(BaCl2) rectifier K+ (KIR) channel Y 
Atenolol (At) Alpha!- adrenoceptor blocker N 
Yohimbine (Yoh) Betai- adrenoceptor blocker N 
Table 3.2. Summary of the pharmacological actions of the inhibitors 
and effects to Fenge 
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B. Danshen aqueous extract 
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Figure. 3.24. Vasodilative effect of 4 mg/ml Danshen aqueous extract on the 
vasoconstriction induced by 60mM KCl (high K) and by 15 nM U46619 (U4). The 
relaxation is of 60mM KCl and the response of U46619-induced tone. The relaxation 
data are shown as mean 士 SD (n=5). *户<0.05 versus U46619-induced control. 
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Figure. 3.25. Effect of Tetraethylammonium (Tea), a non-selective calcium-activated 
K+ channel blocker, on 4 mg/ml Danshen aqueous extract-induced vasodilation. The 
aortic rings were incubated with lOmM Tea 30 min before contraction by 15 nM 
U46619. The relaxation is the response of U46619-induced tone. The relaxation data 
are shown as mean 士 SD (n=5). *户<0.05 versus DS-treated, without Tea control. 
The vasodilative effect of Danshen was partially but significantly abolished when 
the aorta rings were pre-contracted with high potassium. However, by using 
tetraethylammonium to inhibit the potassium channels, the effect of Danshen was not 
much affected (only one point with significant difference). This suggests that the 
potassium channels did not play the main role in the vasodilative effect of Danshen. 
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Figure. 3.26. Effect of Barium Chloride, an inward rectifier K+ channel blocker, on 
4 mg/ml Danshen aqueous extract-induced vasodilation. The aortic rings were 
incubated with 0.3mM BaCl�30 min before contraction by 15 nM U46619. The 
relaxation is the response of U46619-induced tone. The relaxation data are shown as 
mean 士 SD (n=5). 
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Figure. 3.27. Effect of 4-aminopyridine, voltage-dependent K+ channel blocker, on 4 
mg/ml Danshen aqueous extract-induced vasodilation. The aortic rings were 
incubated with 3mM 4-AP 30 min before contraction by 15 nM U46619. The 
relaxation is the response of U46619-induced tone. The relaxation data are shown as 
mean 士 SD (n=5). 
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Agent Pharmacological action Inhibitory 
effect to 
Danshen (Y/N) 
Inhibition of nitric oxide L-NAME N synthase 
Indomethacin (Indo) Inhibition of cyclooxygenase N 
High K+ contraction Closed all the K+ channels Y 
Inhibition of non-selective K+ Tetraethylammonium (Tea) N channel 
Inhibition of voltage-sensitive K+ 4-aminopyridine (4-AP) N (Kv) channels 
Inhibition of voltage-dependent Barium chloride (BaCl�） N 
inward rectifier K+ (Kir) channel 
Atenolol (At) Alpha�- adrenoceptor blocker N 
Yohimbine (Yoh) Betai- adrenoceptor blocker N 




3.6.3 Discussion and summary 
In the present study, we found that D:F (7:3) compound formula, Danshen and 
Fenge aqueous extracts all had abilities to relax the tonic contraction of aortic ring 
induced by U46619. The order of effectiveness were compound formula D:F (7:3) > 
Danshen > Fenge. (Fig 3.3) (with statistic significances). However, their actions were 
not mediated by the same mechanism. 
A. Fense aqueous extract 
The relaxing activity of Fenge was largely attenuated by the removal of 
endothelium (Fig. 3.8). In order to reveal more about the effect of Fenge, L-NAME 
and ODQ, inhibitor of nitric oxide synthase and soluble guanylyl cyclase, respectively, 
were used. The results (Fig 3.9 and Fig 3.10) suggested that the function of Fenge was 
mediated by nitric oxide (NO) pathway as these two inhibitors caused a significant 
rightward shift in curve showing the vasodilative effect of Fenge. 
NO is thought to elicit smooth muscle relaxation primarily through stimulating 
soluble guanylyl cyclase and elevating cyclic GMP (cGMP) (Lincoln et al, 2001). The 
downstream targets of NO are less well defined, although both the large conductance, 
calcium-activated potassium channel and the ATP-sensitive potassium (KATP) channel 
can be activated by NO and / or cGMP (Murphy and Brayden., 1995). Moreover, there 
is growing evidence that indicates that the KATP channel activity may be modulated by 
nitric oxide. In another study (Kubo et al 1993), the researchers demonstrated that NO 
donors cause activation of KATP channels in rat aorta by means of a cGMP-dependent 
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mechanism, possibly the activation of cGMP-dependent protein kinase. For the reason 
that potassium channels are major determinants of membrane potential and vascular 
tone (Nelson and Quayle, 1995). The change in potassium channel activity to alter the 
mobilization of calcium ions subsequently may result in vasodilation (Standen, Quayle, 
1998). That is why we hypothesize that the activation of certain potassium channels 
upon treatment with Fenge extract would result. 
To investigate the involvement of K+ channels and a hyperpolarizing mechanism 
in vasodilation to herbal extracts, 60 mM KCl was used to induce tension (McCulloch 
et al, 1997). In addition, 3mM 4-aminopyridine, a voltage-sensitive K+(Kv) channel 
inhibitor, 0.3mM Barium chloride, a voltage-dependent inward rectifier K+ (Kir) 
channel inhibitor and lOmM tetraethylammonium, a non-selective K+channel inhibitor 
were also independently used to investigate the types of K+ channels that might be 
involved in vasodilative effect of Fenge. 
From Fig 3.20, it is observed that Fenge-induced relaxation was reduced by a high 
extracellular K+ concentration, and thus K+ channels were suspected to be involved in 
this relaxant response. 
Distinct types of potassium channels have been documented in arterial smooth 
muscle cells. Thus, we employed the blockers specific to each subtype of K+ channel 
to assess the action of Fenge. In the presence of tetraethylammonium, a non-selective 
K+ channel inhibitor, the vasodilative effect of Fenge was reduced markedly, it 
confirmed the vasodilative effect of Fenge in aortic rings which pre-contracted with 
high KCl concentration Krebs solution. Action of Fenge was also attenuated by 
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4-aminopyridine, a voltage-sensitive K+(Kv) channel inhibitor and Barium chloride, a 
voltage-dependent inward rectifier K+ (KIR) channel inhibitor. (Fig 3 .22 and Fig 3 .23) . 
The inhibitory effect of glibenclamide, which is a KATP channel inhibitor, was not 
tested yet. In order to better clarify the relationship between the NO-mediated 
vasodilation and KATP channel activation, more study should be conducted in the 
future. 
To explain the blocking effect of 4-aminopyridine and Barium chloride to the 
function of Fenge, some reports claimed that the KATP channels are formed from 
pore-forming and sulphonylurea receptor (SUR) subunits (Babenko et a\, 1998). 
Glibenclamide, which is the most well-known inhibitor for KATP channels, is actually a 
'SUR-binding' inhibitor while 4-AP and BaCl� are 'pore-blocking' inhibitors 
(Surah-Narwal et al, 1999). Therefore, apart from the hypothesis that Fenge can elicit 
the direct effect on the voltage-sensitive K+ (Ky) channel and voltage-dependent 
inward rectifier K+ (Kir) channel in vascular smooth muscle, one should not exclude 
the possibility that Fenge might also somehow activates the KATP channels via the 
enhancement of NO production (NO-mediated pathway). 
In summary, these results suggested that the vasodilative effect of Fenge is most 
likely mediated via activation of NO /sGC /cGMP pathway, as well as stimulation of 
the voltage-sensitive K+ (KY) channel and voltage-dependent inward rectifier K+ (KIR) 
channel. And from all the data related to the action of blockers and inhibitors, they 
partially but not totally abolished the relaxation induced by Fenge. It is quite possible 
that the vascular relaxation of Fenge is multi-factorial. 
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Fig 3.28. Summary of hypothesized vasodilative effect of Fenge 
B. Danshen aqueous extract 
The vasodilative effect of Danshen was disparate to that of Fenge. From Fig 3.13 
and 3.14, L-NAME and indomethacin failed to modify the action of Danshen, meaning 
that the vasodilative effect of Danshen is endotheliuin-independent. Furthermore，in 
the presence of atenolol and yohimbine (Fig 3.17 and Fig 3.18), it again did not show 
any difference for the vasodilative function of this herbal extract. Danshen, therefore, 
did not elicite any relaxing effect via alpha 2 and beta 1 adrenocepter. 
In the experiments of potassium channels inhibitors, only tetraethylammonium 
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treatment and when intact-aorta were contracted with high K+ concentrations, the 
function of Danshen was affected. However, the effects were weak (but significant) in 
the reduction of the relaxation. In fact, the reduction of vasodilative effect of Danshen 
in high K+ concentration implied that potassium channels might be involved in the 
effect of Danshen. Therefore, more potassium channel inhibitors should be used in 
order to justify this issue. Some potential inhibitors include apamin (calcium-sensitive 
small conductance K+ channel inhibitor), charybdotoxin (LKca channel blocker) and 
glibenclamide (KATP channel blocker) which can be tested in the future. 
As the matter of fact, in blood vessels, the ability to control vascular tone also 
depends on extracellular calcium entry, as well as the release of calcium from inositol 
1,4,5-trisphosphate receptor (IP3R)-gated stores which are located in both the 
endothelial and smooth muscle cells of the vascular wall (Grayson et al, 2004). It is the 
most direct and the final step for relaxation of SMC. Apart from seeking other 
possibilities of adrenoceptors and potassium channels, the effect of Danshen to 
voltage-gated calcium channel is also worthwhile investigating in the future. 
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3.7 Potential active components from Fenge and Danshen 
The vasodilative effect of Danshen and Fenge aqueous extracts were well 
demonstrated in many research studies previously (Song et al, 1988 and Kamata et al, 
1994). Mostly, their dose dependent effects were tested in organ baths with different 
kinds of arterial models, such as aorta and mesenteric artery. In this project, a few pure 
compounds from Fenge and Danshen were chosen for vasodilation study. The 
concentrations used were calculated from their percentage content of the raw herbal 
material (reference from the HPLC profile). If certain compounds are effective in the 
vasodilative functional tests compared to that of the corresponding herbal extract, one 
may suggest that this is the 'active component' for vasodilative effect. 
3.7.1 Materials and Methods 
The same as section 3.3.1，with the following amendments: 
Chemicals 
The pure compounds were kindly purified by Dr. Jiang Ren-Wang, Institute of 
Chinese Medicine, The Chinese University of Hong Kong (Daidzein and Daidzin). 
Salvianolic acid B (SAB) was kindly purified by Ms Chan Ying-Ling, Institute of 




A, Daidzin (From Fenge) 
120 ——— 
100 _ T 
^ 40 - ( if, jJ -H»-FG4mg/inl 
T / * l y ^ - O - D a i d z i n 0.0112 
— J r ^ ^  
0 1 i I 1 ^ I „ 
0 20 40 60 80 100 120 140 
time (min) 
Figure 3.29 Fenge contains 0.28 % daidzin, which is resulted from the 
semi-quantitative analysis (Jiang et al, 2004). 4 mg/mlx 0.28% = 0.0112 mg/ml. 
Compared to 4mg/ml Fenge, daidzin contribute greatly to relax the aortic rings. The 
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Figure. 3.30. This graph showed that daidzin may elicit vasodilative effect by 
opening of some potassium channels in blood vessel. The relaxation data are shown 
as mean 士 SD (n=4). *P<0.05 daidzin versus wE FG-treated control. 
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B. Daidzein (From Fengp) 
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Figure.3.31. Fenge contains 0.05 % daidzein, which is resulted from the 
semi-quantitative analysis (Jiang et al, 2004). 4 mg/mlx 0.05 % = 0.002 mg/ml. The 
relaxation data are shown as mean 士 SD (n=4). 
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c. Salvianolic acid B (From Danshen) 
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Figure. 3.32. Danshen contains 3 % Salvianolic acid B: 4 mg/mlx 3% = 0.12 mg/ml, 
which is referenced from Hong Kong Institute of Biotechnology (HKIB). The 




Fenge and Danshen were both popular herbs, many compounds purified from 
them were well-studied. In the present test, in order to study the vasodilative effects of 
Fenge and Danshen deeper, a few compounds purified in our lab were tested in organ 
bath experiments. 
As shown by Fig 3.29 - Fig. 3.32, it can be shown that daidzin and salvianolic 
acid B were potential active compounds from Fenge and Danshen, respectively. For 
daidzin, its effect was further tested in aortic rings contracted by high K+ concentration, 
and its vasodilative effect was greatly decreased. Further study for underlying 
mechanism of these two compounds and a search for more novel potential active 
components will be valuable, for the reason that if the compounds are more specific, 
the results will give a clearer picture. 
Puerarin, which is abundant in Fenge, was reported to possess vasodilative effect 
(Dong et al, 2004), via the activation of the potassium channels (Kv and Kir，but not 
KATP)- IT is one good model for us to further investigate the mechanism involved in 
vasodilative effect of other active component from Fenge and Danshen. 
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Chapter 4 Comparison ofFenge and Yege 
Two species of herbal sources, Pueraria lobata (Willd.) Ohwi (Yege) and Pueraria 
thomsonii Benth (Fenge), were interesting due to their differences in terms of 
cardiovascular tonic effects. In this part of my thesis, their vasodilative effects, 
antioxidative effects as well as protective effects for ischemia reperftision of heart will 
be compared. 
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4.1 Vasodilative Effects of Fenge and Yege 
4.1.1 Materials and Methods 
Same as described in section 3.3.1 
4.1.2 Results 
4.1.2.1 Comparison between the vasodilative effect of Yege and Fenge 
— 
1 6 0 -
o / * / |H>~D:Y(7:3)| 
^ y y 國 I 
^^ Q^ 1 1 1 1 1 I I  -10 10 30 50 70 90 110 130 150 
Time (min) 
Figure 4.1. Vasodilative effect of D:Y (7:3) and D:F (7:3) aqueous extract. The 
relaxation is the response of U46619-induced tone. The relaxation data are shown as 
mean 士 SD (n=5). *P<0.05 D:Y (7:3) versus D:F (7:3). 
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Figure 4.2. Vasodilative effect of Fenge and Yege aqueous extract. The relaxation is the 
response the response of U46619-induced tone. The relaxation data are shown as mean 
士 SD (n=5). *尸<0.05 Yege versus Fenge. 
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4.1.2.2 Underlying Mechanism of Yege 
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Figure 4.3. Endothelium dependent vasodilation of 4 mg/ml Yege. (wE) represents 
with endothelium, (woE) represents without endothelium. The relaxation is the 
response of U46619-induced tone. The relaxation data are shown as mean 士 SD (n=5). 
*P<0.05 woE versus wE FG-treated control. 
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Figure. 4.4. Effect of L-NAME, an inhibitor of NO synthase, on Yege aqueous 
extract-induced vasodilation. The aortic rings were incubated with lOOjiM L-NAME 
30 min before contraction by 15 nM U46619. The relaxation is the response of 
U46619-induced tone. The relaxation data are shown as mean 士 SD (n=5). *P<0.05 
versus YG-treated, without L-NAME control. 
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Figure 4.5. Effect of ODQ, an inhibitor of soluble guanlyly cyclase, on Yege aqueous 
extract-induced vasodilation. The aortic rings were incubated with IjoM ODQ 30 min 
before contraction by 10 nM U46619. The relaxation is the response of 
U46619-induced tone. The relaxation data are shown as mean 士 SD (n=5). *P<0.05 
versus YG-treated, without ODQ control. 
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Figure 4.6. Effect of indomethacin, an inhibitor of cyclooxygenase, on Yege aqueous 
extract-induced vasodilation. The aortic rings were incubated with 1 fiM indomethacin 
30 min before contraction by 15 nM U46619. The relaxation is the response of 
U46619-induced tone. The relaxation data are shown as mean 士 SD (n=5). 
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Figure 4.7. Effect of Atenolol, a beta 1 -adrenoceptor blocker, on 4 mg/ml Yege aqueous 
extract-induced vasodilation. The aortic rings were incubated with lOjuM Atenolol 30 
min before contraction by 15 nM U46619. The relaxation is the response of 
U46619-induced tone. The relaxation data are shown as mean 士 SD (n=5). 
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Figure. 4.8. Effect of yohimbine (yoh), alpha2-adrenoceptor blocker, on 4 mg/ml Yege 
aqueous extract-induced vasodilation. The aortic rings were incubated with l|uM 
yohimbine 30 min before contraction by 15 nM U46619. The relaxation is the response 
of U46619-induced tone. The relaxation data are shown as mean 士 SD (n=5). 
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Figure. 4.9. Vasodilative effect of 4 mg/ml Yege aqueous extract on the 
vasoconstriction induced by High potassium concentration (60mM KCl) and by 15 
nM U46619. The relaxation is the response of High K+/ U46619-induced tone. The 
relaxation data are shown as mean 士 SD (n=5). *尸<0.05 versus U46619-induced 
control. 
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Figure. 4.10. Effect of Tetraethylammonmm(tea), a non-selective calcium-activated K+ 
channel blocker, on 4 mg/ml Yege aqueous extract-induced vasodilation. The aortic 
rings were incubated with lOmM tea 30 min before contraction by 15 nM U46619. The 
relaxation is the response of U46619-induced tone. The relaxation data are shown as 
mean 士 SD (n=5). *P<0.05 versus YG-treated, without tea control. 
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Figure 4.11. Effect of 4-aminopyridine (4-AP), a voltage-dependent K+ channel 
blocker, on 4 mg/ml Fenge aqueous extract-induced vasodilation. The aortic rings were 
incubated with 3mM 4-AP 30 min before contraction by 15 nM U46619. The 
relaxation is the response of U46619-induced tone. The relaxation data are shown as 
mean 士 SD (n=5). *P<0.05 versus YG-treated, without 4-AP control. 
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Figure 4.12. Effect of Barium Chloride, an inward rectifier K+ channel blocker, on 4 
mg/ml Fenge aqueous extract-induced vasodilation. The aortic rings were incubated 
with 0.3mM BaCli 30 min before contraction by 15 nM U46619. The relaxation is 
the response of U46619-induced tone. The relaxation data are shown as mean 士 SD 
(n=5). *P<0.05 versus YG-treated, without BaCl� control. 
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4.1.3 Discussion 
Agent Pharmacological action Inhibitory effect Fenge 
to Yege (Y/N) (Y/N) 
L-NAME Inhibition of nitric oxide synthase Y Y 
ODQ Inhibition of soluble guanylate 
cyclase 
Indomethacin Inhibition of cyclooxygenase N N (Indo) 
High K+ contraction Closed all the K+ channels Y Y 
Tetraethylammonium Inhibition of non-selective K+ 
Y Y 
(Tea) channel 
4-aminopyridine Inhibition of voltage-sensitive K+ 
Y Y 
(4-AP) (Kv) channels 
Barium chloride Inhibition of voltage-dependent 
+ Y Y 
(BaCli) inward rectifier K+ (KIR) channel 
Atenolol (At) Alpha�- adrenoceptor blocker N N 
Yohimbine (Yoh) Betai- adrenoceptor blocker N N 
Table 4.1. Summary of the pharmacological actions of the inhibitors and effects to Yege 
and Fenge 
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Fig 4.13. Summary of hypothesized vasodilative effect of Yege 
The vaosdilative effect of Yege was similar to that of Fen织.The chemical content 
of Fenge and Yege are similar (will be discussed in chapter 5). Their mechanisms in 
vasodilation were similar but Yege elicited greater effect, 
Jiang et al compared the chemical profile (HPLC fingerprint) and antioxidative 
effect of Fenge and Yege previously (Jiang et al, 2004). The chemical content in Yege 
was similar to that of Fenge while the former has higher amount The antioxidant assay 
also suggested that Yege was more potent than that of Fenge. 
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The vasodilative effect of Yege and Fenge had not been studied before. The 
results obtained in this project gave a milestone to the use of Yege and Fenge to treat 
hypertension. They also shared common pathways in vasodilation. Therefore, these 
two herbs can be regarded as variant based on their similarity of biological activity. 
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4.2 The Comparison of Antioxidative Effect between Yege and Fenge 
The recent development of free radical biology and medicine has provided a large 
body of clinical and experimental evidence showing that free radical induced 
peroxidation of membrane lipids is associated with a variety of chronic health 
problems, such as cancer, atherosclerosis and ageing (Kuang et al, 1998) .Therefore, 
antioxidant therapy has become an attractive therapeutic strategy. Reactive oxygen 
species are thought to be involved in the damage of biomembranes during ischemia, 
inflammation and aging. It has been shown that low vitamin E in red blood cell 
membranes is associated with an increased susceptibility to hemolysis 
(Delmas-Beauvieus et al, 1995). 
Red blood cell (RBC) membrane is rich in polyunsaturated fatty acids which are 
very susceptible to free radical mediated peroxidation. Thermal decomposition at 
physiological temperature of a water-soluble azo compound, 
2,2-azobis(2-amindinopropane) dihydrochloride (AAPH) (Fig 4.14), generates 
initiating free radicals which could attack the RBC membrane to induce lipid 
peroxidation and eventually cause hemolysis (Figure 4.15). Since the rate of free 
radical generation from AAPH can be easily controlled and measured, the hemolysis 
induced by AAPH provides a good approach for studying the free radical induced 
membrane damage (Niki et al, 1988). In this project, AAPH was used as the external 
radical source to induce the oxidative hemolysis of rat red blood cells and to study the 
inhibitory effect / antioxidative effect of different herbal extracts. 
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Figure 4.14 Chemical structure of AAPH 
Chain initiation: 
A-N=N-A (AAPH) + 
[A N2 A] (In the presence of O2+ 2AOO N2 (1) 
AOO + LH (In the presence of O2 ^ AOOH + LOO (2) 
Chain propagation : 
LOO + LH + LOOK + L (3) 
L + 0 2 ^ L 0 0 (4) 
Remark: A : HCl NH = C(NH2) - C(CH3)2 
Figure. 4.15. The oxidation of lipid (LH) in RBC membranes proceeds by a free radical 
chain mechanism as shown in the schematic drawing. One single initiating radical can 
produce many lipid hydroperoxides and eventually cause membrance damage. 
Two models were applied to compare the antioxidant effect of Fenge, Yege, 
Danshen as well as the extracts of compound formula in this project. They are AAPH 
induced red blood cell hemolysis (Section 4.2) and ischemia reperfusion (IR) of 
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isolated rat heart on Langendorff apparatus (Section 4.3). 
4.2.1 Red blood cell hemolysis model 
An inhibition of 2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH) induced 
red blood cell hemolysis experiment has been carried out to examine the antioxidant 
ability of the herbal extracts. As the oxidation of LDL to ox-LDL is the very first step 
in foam cell formation and atherosclerosis, this model could be a suitable method to 
evaluate one of the pharmacological functions of herbal extracts toward the 
cardiovascular diseases. 
4.2.1.1 Materials and Methods 
Animals 
320-350 g Sprague-Dawley (SD) rat RBCs were separated from heparinized 
blood. The blood was centrifuged at 1500 x g for 10 min to separate the RBC from the 
plasma, and then the RBC was washed two times with 0.15 M NaCl solution, followed 
by 1500 x g centrifugation for 10 min twice. During the last washing, the cells were 
centrifuged at 1000 x g for 10 min to obtain a constantly packed cell volume. The 
volume of red blood cell was measured and 4 times volume of 0.1 M 
phosphate-buffered saline (PBS) was added to obtain a 20% red blood cell suspension. 
Lysis reaction 
Herbal extracts were weighed and dissolved in PBS. Serial dilutions were 
performed to obtain various concentrations of herbal extracts. Each reaction mixture 
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contained a final volume of 1 ml including 10% red blood cell suspension, 100 mM 
AAPH，and extracts. Final concentrations of the samples were 1 mg/ml, 500 |ag/ml, 
250 jig/ml, 125 |ig/ml and 62.5 ^ig/ml (2-fold dilution). Control reactions were set by 
using PBS instead of drug samples. The mixtures were shaken gently and then 
incubated under air atmosphere at 37�C for 200 min with oscillation. 
Determination of cell lysis 
The incubated reaction mixtures were diluted 20 fold in PBS (A) and distilled 
water (B) separately. They were shaken gently and then centrifliged at 1500 x g for 10 
min to separate the RBC. 200 [i\ of supernatant were transferred to flat bottom 96-well 
plates. The absorbance A (from PBS) of the supernatant at 540nm was measured. 
Similarly, the reaction mixture was also treated with distilled water to make complete 
hemolysis (B). The absorbance B of the supernatant after centrifiigation was measured 
at 540 nm, also. Percentage inhibition was calculated by the following equation: 
Inhibition % = [(B-A) / B - (B control - A control)丨 B control] 
The 50% Inhibition Concentrations (IC50) were used to compare the potency of the 
herbal extracts. 
-107 -
Comparison Between Yege and Fenge 
4.2.1.2 Results 
The percentage inhibition of red blood cell hemolysis was plotted against the dose 
concentration of the three samples, Danshen, compound formula with Fenge 7:3 (D:F) 
and those with Yege 7:3 (D:Y) • As shown in figure 4.16, these two compound 
formulae showed similar IC50 with no significant difference. The inhibitory effects of 
all aqueous extracts were saturated at about 0.6 mg/ml. IC50 of Danshen, 7:3(D:F) and 
7:3 (D:Y) were 0.31 mg/ml, 0.32mg/ml, 0.35 mg/ml, respectively. 
y (Inhibition saturated) 
I CO - / ~^7:3(D:F) 
棚 y f 
出 10 - / 
^ I I I I I: 
_ 1Q ^ 0:2'"士" 0:4' Q-g - t" T! 2 
Concentration (mg/ml) 
Figure 4.16. Inhibitory effects of Danshen, compound formula with Fenge 7:3 (D:F) 
and those with Yege 7:3 (D:Y) against AAPH-induced hemolysis of 10% rat RBC, 
initiated with lOOmM AAPH under air atmosphere at 37 °C • Doses used of the 
extracts were 1 mg/ml, 500 |ig/ml, 250 |ig/ml, 125 |ig/ml and 62.5 |ig/ml. Data are 
expressed as mean 土 SD of n=7. 
The percentage inhibition of red blood cell hemolysis was plotted against the 
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concentrations of the Yege and Fenge aqueous extracts. As shown in figure 4.17, both 
of these herbal extracts possess mild antioxidative effect in lower dose (62.5 |Lig/ml to 
500 |ig/ml). However, at the higher dose of Yege, its potency was greatly increase and 
showed IC50 = 0.85 mg/ml, it was better than that of Fenge, which IC50 was 
undetectable. The inhibitory effects of both compound formula extracts (Fig 4.16) were 
saturated at about 0.6 mg/ml. IC50 of Fenge could not be detected within 1 mg/ml dose 
range. 
90 - I 
5 i F G T 
I 70 _ ^ 
_ 5 � - T . / 
I 30 - L / * 
羞 _ I 
-10 —OTZ "d:6 v:s r— 1:2 
Concentration (mg/ml) 
Figure 4.17. Inhibitory effects of Yege and Fenge aqueous extracts against 
AAPH-induced hemolysis of 10% rat RBC, initiated with lOOmM AAPH under air 
atmosphere at 3 7 � C. Doses used of the extracts were 1 mg/ml, 500 |ig/ml, 250 |ig/ml, 
125 i^g/ml and 62.5 |ig/ml. IC50 were 0.8 mg/ml and undetectable, respectively. Data 
are expressed as mean 士 SD of n=5. 
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4.2.1.3 Discussion 
The 50% inhibition concentrations (IC50) were used to compare the potency of 
the herbal extracts. The lower of the IC50 value means the sample can inhibit the lysis 
of half of RBC in the presence of AAPH at lower dose, thus representing the higher of 
its potency to protect the RBC from AAPH-induced hemolysis. Danshen, two 
compound formulae with Yege and Fenge were almost the same in terms of their 
inhibitory effects in this experiment. They showed similar and neglectable difference 
IC 50: 0.32mg/ml, 0.35 mg/ml, respectively. 
To compare the inhibitory effects of all the extracts, Danshen and two compound 
formulae have similar effect while the effects of Yege and Fenge were almost negative 
at lower dose (62.5 |ag/ml to 500 lag/ml). It implies that the effects of two compound 
formulae within this range were mostly attributed to Danshen. As result, in terms of 
antioxidative effect, two compound formulae (containing Fenge and Yege) had no 
synergistic effect. 
From this test, compound formulae and Danshen gave higher inhibitory effects to 
the AAPH-induced RBC hemolysis than that of individual Fenge and Yege. 
Antioxidant is able to prevent the oxidation of LDL, which will further step into form 
cell formation. Therefore, compound formulae and Danshen are regarded to be the 
better choice to prevent atherosclerosis than individual Fenge and Yege. The daily 
supplement of compound formulae and Danshen may maintain a high level of 
antioxidant that slows down the chance of atherosclerosis formation. 
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Danshen is also the potent antioxidant while the positive effect of Yege should not 
be neglected as it showed inhibitory effect at higher dosage. 
This model is an in vitro assay and may not completely reflect the real situation 
of the extracts when they were entered into the body. One possible method could be 
used to access how the digestion procedure affects the effectiveness of drugs. Since 
this extracts are targeting on cardiovascular system, the blood sample could be 
prepared after feeding the rat for a period of time. By this way, the stability and 
transformation (if any) of herbal extracts could be evaluated. 
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4.2.2 Ischemia-reperfusion on Langendroff 
Myocardial ischemia initiates a range of cellular events. The damage caused 
during ischemia is called "ischemic injury". Although reperfusion means a termination 
of ischemia and is essential for the cell to survive as well as to restore normal function, 
it paradoxically causes damage to the cell; this injury is called "reperfusion injury". 
(Rie Kato et al, 2002). 
To compare the protective effect of the herbal extracts (Yege and Fenge) on the 
ischemia-reperfusion injury, an isolated rat heart was cannulated on a Langendorff 
apparatus and an ex-vivo ischemia-reperfusion injury assay was performed. Herbal 
extracts were added 1 min before reperfusion in order to investigate the protective 
effects against the ischemia-reperfusion injury. Four parameters were monitored in 
order to evaluate the heart function in the presence of the herbal extracts. They are: the 
recovery of heart contractile force, the recovery of coronary flow rate, and the heart 
specific enzyme activities: creatine kinase (CK) and lactate dehydrogenase (LDH) 
CK and LDH are two commonly used enzymes indicating the damage level of 
tissues such as liver and heart. 
CK plays an important role in muscle by providing ATP, when muscle contacts, 
from ADP and using creatine phosphate as the phosphorylation reservoir. Serum CK 
concentration is greatly elevated in patients with some diseases of the central nervous 
system (acute cerebrovascular disease, cerebral ischemia, etc). After a myocardial 
infarction, CK leakage will remarkably increase so that it is one of the diagnostic 
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indicators for the heart disease. 
Similarly, elevation in serum LDH occurs with myocardial infarction and liver 
diseases, and it also provides a definite diagnosis of acute myocardial infarction. LDH 
specifically catalyzes the oxidation of lactate to pyruvate with the subsequent reduction 
of NAD to NADH. The rate at which NADH forms is proportional to LDH activity. 
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4.2.2.1 Materials and Methods 
Chemicals 
Heparin sodium salt from porcine intestinal mucosa, creatine kinase diagnostic kit 
and lactate dehydrogenase diagnostic kit were purchased from Biosystems. Krebs 
solution (118.0 mM NaCl, 4.7 mM KCl, 1.64 mM MgS04, 1.2 mM KH2PO4, 5.55 mM 
D-glucose, 25.0 mM NaHCOs and 2.5 mM CaCy was adjusted to pH 7.4 and filtered. 
Animals 
220-250 g male Sprague-Dawley (SD) rat was killed by cervical dislocation. The 
heart was excised within 1 minute. The isolated heart was immediately put into 
ice-cooled Krebs solution containing 50 unit/ml heparin to prevent blood clotting. The 
surrounding connective tissues and fats were quickly removed so that a single opening 
aorta was recognized. The excised heart was cannulated on a Langendroff apparatus. 
Ischemia-Reperfusion on Langendorff apparatus 
The aorta of rat heart was cannulated on the Langendorff apparatus and fixed 
tightly by a piece of string. 37 °C pre-warmed and 95% oxygen with 5% carbon 
dioxide gassed Krebs solution was perfused into the heart. A basal force was applied to 
the rat heart to induce its contraction. This force was gradually increased up to 2 g. The 
rat heart was equilibrated for 20 minutes before starting. After 10 minutes and 20 
minutes, perfusate from the heart was collected for 1 minute. The supply of Krebs 
solution was stopped right after the collection of minute perfusate, and the heart 
was under ischemia for 29 minutes. 0.2ml of drug sample (Krebs solution as control) 
was then injected to the reservoir after 29 minute, followed by a 15-minute reperfusion. 
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After 15 minutes, the perfusate was collected per 1 minute and finally, 17 samples for 
each heart were collected, 15 samples in reperfusion together with those from the 10出 
and 20th minute before ischemia. 
Contractile force measurement 
The contractile forces / tensions were transfer from a string to the Grass 
force-displacement transducers, FT-03E and recorded by MacLab data acquisition 
system. Data was recorded by a sampling rate of 10 per second. The percentage 
contractile force recovery was the contractile force during reperfusion compared to the 
average values at the minute and the minute before ischemia. 
Coronary flow rate measurement 
The coronary heart perfusate was collected and measured for 1 minute during 
reperfusion period. Assuming that the density of the heart perfusate is 1 g/ml, same as 
distill water, the weight (g) of the heart perfusate collected in each 1 minute is the 
average flow rate in that minute with unit of ml/min. The percentage coronary flow 
rate recovery was the coronary flow rate during reperfusion compared to that of 
average values at the IQth minute and 20丈乜 minute before ischemia. 
Lactate dehydrogenase activity measurement 
50 III heart perfusate was added to a pre-wanned 30°C cuvette containing 0.5 ml 
lactate dehydrogenase reagent (biosystems) and mixed by inversion. After 1 minute 
incubation, the absorbance was read at wavelength 340 nm using water as the blank. 
Absorbances were read at 15-second intervals for 60 seconds in total. The activity of 
lactate dehydrogenase in the unit of U/L is the change of absorbance (OD measurement) 
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per minute (AA/min) times 1768. 
Creatine kinase activity measurement 
100 |il heart perfusate was added to a pre-warmed 30�C cuvette containing 0.5 ml 
creatine kinase reagent (biosystems) and mixed by inversion. After 1 minute incubation, 
the absorbance was read at wavelength 340 nm using CK reagent as blank. 
Absorbances were read at 15-second intervals for 60 seconds in total. The activity of 
creatine kinase in the unit of U/L is the change of absorbance per minute (AA/min) 
times 952. 
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4.2.2.2 Results 
A. Accumulating Leakage of CK and LDH 
十 
18 T ^ —Contro l JI 
g - « - D : F (7:3) 8 mg/ml 乂 
2 14 -ik-DiY (7:3) 8 mg/ml 丁 7 
I 丨:： 
丨: 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 time / min 
Figure. 4.18. Accumulating leakage of creatine kinase of ischemia-reperfusion injured 
heart protected by D:F (7:3) and D:Y (7:3) compound formula at 8 mg/ml. Data are 
shown as mean 土 SD of 5 rat hearts for each group. 
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Figure. 4.19. Accumulating leakage of lactate dehydrogenase of ischemia-reperfusion 
injured heart protected by D:F (7:3) and D:Y (7:3) compound formula at 8 mg/ml. Data 
are shown as mean 士 SD of 5 rat hearts for each group. 
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a 
旨 士 YG8mg/ml 
U 10 ~»~-FG8mg/ml ^ r ^ 
I 8 — 1 」 ^ ^ ^ ^ ^ ^ ^ I 
^ Q _I I I I I I I I I I I I 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
time / min 
b 
Control FG YG 
Time ；： SD (%) mean (%) SD (%) mean (%) SD (%) 
1 0 . 4 5 4 8 7 ± 0 . 3 9 5 1 2 0 . 2 0 3 6 9 ± 0 . 0 6 3 9 5 0 . 1 5 2 8 3 ± 0 . 0 7 1 2 1 5 
2 0 . 4 3 4 6 4 土 0 . 2 4 6 6 9 0 . 3 1 1 5 4 ± 0 . 1 6 3 4 6 0 . 2 6 3 4 6 土 0 . 1 3 7 2 2 1 
3 0 . 7 3 6 0 7 ± 0 . 2 6 7 4 2 0 . 6 4 5 3 8 ± 0 . 2 8 1 9 0 . 4 7 9 2 3 ± 0 . 1 7 8 7 8 2 
4 1 . 2 1 4 9 7 ± 0 . 4 2 4 5 7 1 . 1 7 3 8 6 ± 0 . 5 5 1 3 0 . 8 6 7 4 1 ± 0 . 4 1 0 2 0 4 
5 2 . 0 4 3 3 4 ± 0 . 7 3 4 0 1 1 . 9 6 2 1 3 ± 1 . 0 0 1 9 1 . 4 2 8 7 2 ± 0 . 8 2 2 5 7 5 
6 2 . 8 9 4 0 9 ± 1 . 1 9 2 5 6 2 . 9 1 4 3 5 ± 1 . 6 1 2 6 7 2 . 1 4 6 7 4 ± 1 . 1 4 6 0 8 8 
7 3 . 8 9 7 6 3 ± 1 . 5 8 3 4 7 3 . 9 7 9 6 4 ± 2 . 2 7 5 9 7 3 . 1 3 0 9 5 ± 1 . 6 6 3 3 3 7 
8 4 . 8 7 3 4 6 ± 1 . 7 9 5 8 5 . 0 6 1 0 2 ± 2 . 9 8 0 7 7 4 . 0 8 7 0 5 ± 2 . 0 8 8 9 7 7 
9 5 . 9 5 8 8 6 ± 2 . 1 2 1 5 1 6 . 1 3 6 6 6 ± 3 . 6 6 4 8 9 5 . 0 6 0 8 7 ± 2 . 4 9 6 0 5 1 
1 0 6 . 9 9 8 4 1 ± 2 . 3 9 4 6 9 7 . 2 2 0 9 7 ± 4 . 4 2 5 1 1 6 . 0 8 2 6 5 ± 3 . 0 0 5 1 0 8 
1 1 8 . 1 8 6 4 1 ± 2 . 6 5 8 8 8 8 . 3 5 6 9 7 ± 5 . 1 0 2 5 7 7 . 0 3 8 8 ± 3 . 4 1 5 2 1 1 
1 2 9 . 4 9 2 8 1 ± 2 . 7 8 7 9 4 9 . 4 7 0 3 8 ± 5 . 8 4 7 1 9 7 . 9 4 4 5 6 ± 3 . 8 1 0 6 2 2 
1 3 1 0 . 6 2 0 8 ± 2 . 6 8 8 1 1 0 . 5 7 5 6 ± 6 . 6 3 1 6 4 8 . 7 9 6 9 9 ± 4 . 1 2 2 2 1 4 
1 4 1 1 . 6 6 5 6 ± 2 . 6 7 4 5 1 1 1 . 6 5 2 5 ± 7 . 2 7 7 6 1 9 . 6 3 9 6 5 ± 4 . 3 9 8 5 4 9 
1 5 1 2 . 6 6 2 8 土 2 . 6 3 9 9 9 1 2 . 5 9 1 5 ± 7 . 8 9 5 1 7 1 0 . 2 8 2 5 ± 4 . 6 0 5 6 9 1 
Figure. 4.20. a) Accumulating leakage of creatine kinase of ischemia-reperflision 
injured heart protected by FG and YG 8 mg/ml. b) Data are shown as mean 士 SD of 5 
rat hearts for each group. The SD error bar was not shown in graph for curve clearness. 
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a 
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S 4 - i i - F G 8 mg/ml ^ ^ ^ 
I 士 YG 8 mg/ml ^ ^ ^ 
Q 1 fin I i I 1 I 1 1 I I I I I I i 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
time / min 
b 
Control FG YG 
Time mean (%) SD (%) mean (%) SD (%) mean (%) SD (%) 
1 0 . 2 4 8 1 5 9 ± 0 . 1 7 7 6 5 0 . 3 4 3 9 7 ± 0 . 3 9 1 6 4 0 . 1 2 7 9 8 ± 0 . 0 2 9 8 
2 0 . 2 3 4 2 9 4 ± 0 . 0 9 8 5 0 . 2 5 9 2 7 ± 0 . 1 1 0 7 3 0 . 2 0 3 4 1 ± 0 . 0 6 1 6 
3 0 . 4 0 2 7 5 5 土 0 . 1 1 8 8 4 0 . 4 1 3 8 6 土 0 . 1 6 9 8 5 0 . 2 6 5 7 2 土 0 . 0 5 4 
4 0 . 6 4 0 6 9 2 ± 0 . 2 4 9 2 0 . 6 3 8 0 9 ± 0 . 2 6 7 3 4 0 . 3 5 4 2 9 ± 0 . 1 3 4 4 
5 0 . 9 3 0 9 4 3 土 0 . 3 9 1 4 5 0 . 9 3 7 5 2 ± 0 . 4 0 4 0 . 5 1 2 3 9 土 1 . 9 2 1 
6 1 . 3 2 4 1 9 5 ± 0 . 5 4 0 3 9 1 . 2 8 7 6 3 ± 0 . 5 9 9 7 5 0 . 7 8 5 3 9 ± 2 . 0 2 8 9 
7 1 . 7 3 9 8 2 2 ± 0 . 6 8 7 2 1 1 . 7 3 2 7 9 ± 0 . 8 7 6 5 2 1 . 0 6 4 9 8 ± 2 . 1 5 5 3 
8 2 . 1 2 9 4 9 1 ± 0 . 7 6 0 1 9 2 . 1 6 9 1 3 土 1 . 1 3 6 5 6 1 . 4 1 4 7 2 ± 2 . 2 3 4 5 
9 2 . 6 0 1 1 0 6 土 0 . 8 3 5 9 5 2 . 5 9 土 1 . 3 8 9 2 1 . 7 6 0 7 4 土 2 . 3 2 4 4 
1 0 3 . 0 4 9 7 1 6 ± 1 . 0 1 8 2 4 3 . 0 3 0 8 7 ± 1 . 6 5 5 8 2 . 1 3 2 9 4 ± 2 . 3 8 7 8 
1 1 3 . 7 9 5 7 7 4 ± 1 . 0 3 0 4 3 3 . 4 9 7 9 3 ± 1 . 8 7 8 2 6 2 . 4 8 9 7 4 ± 2 . 4 7 4 8 
1 2 4 . 2 5 7 0 2 3 ± 1 . 1 0 2 7 7 3 . 9 2 3 9 4 土 2 . 0 8 4 1 8 2 . 8 1 8 3 5 ± 2 . 5 4 1 7 
1 3 4 . 6 8 6 0 8 8 ± 1 . 1 5 9 2 8 4 . 4 0 1 7 3 ± 2 . 3 4 8 5 9 3 . 0 7 3 8 1 ± 2 . 5 0 8 3 
1 4 5 . 0 6 7 1 0 8 土 1 . 2 4 1 1 3 4 . 8 3 2 4 3 土 2 . 5 1 2 3 7 3 . 4 5 5 3 1 土 2 . 5 8 7 4 
1 5 5 . 3 8 8 6 6 7 ± 1 . 4 1 5 1 7 5 . 2 8 6 2 ± 2 . 7 2 3 0 3 3 . 8 5 2 6 4 ± 2 . 6 3 1 1 
Figure. 4.21 .a) Accumulating leakage of lactate dehydrogenase of 
ischemia-reperfusion injured heart protected by FG and YG at 8 mg/ml. b) Data are 
shown as mean 土 SD of 5 rat hearts for each group. 
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Figure. 4.22. Contractile force recovery of ischemia-reperfusion injured heart protected 
by D:F (7:3) and D:Y (7:3) compound formula at 8 mg/ml. Data are shown as mean 土 
SD of 5 rat hearts for each group. 
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B. Contractile Force Recovery 
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Figure. 4.23. Contractile force recovery of ischemia-reperfusion injured heart protected 
by FG and YG at 8 mg/ml. Data are shown as mean 土 SD of 5 rat hearts for each 
group. 
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B. Coronary Flow Rate Recovery 
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2 4 1 . 0 9 8 4 土 1 7 . 1 0 6 8 5 4 . 6 0 2 6 ± 1 7 . 0 5 3 1 2 8 . 7 0 2 土 2 1 . 0 9 8 1 
3 4 7 . 8 2 5 7 土 1 7 . 8 7 9 5 5 . 5 3 3 8 ± 2 0 . 0 6 0 8 3 1 . 0 5 9 6 ± 2 2 . 0 1 1 
4 5 2 . 4 9 6 8 土 1 6 . 7 6 2 9 5 1 . 7 1 1 2 土 2 2 . 5 1 3 7 3 1 . 2 4 2 7 土 2 1 . 6 9 9 6 
5 5 5 . 2 3 0 6 ± 1 6 . 4 0 7 5 5 2 . 9 0 3 7 ± 2 3 . 8 0 7 3 2 . 3 8 5 5 ± 2 2 . 3 9 9 9 
6 5 4 . 5 2 7 7 ± 1 9 . 1 7 2 6 5 5 . 7 5 8 4 ± 2 2 . 4 2 4 1 3 3 . 8 6 4 7 土 2 2 . 3 7 9 1 
7 5 9 . 9 6 7 1 ± 1 5 . 1 6 6 6 6 0 . 0 9 5 6 ± 2 6 . 2 4 1 9 3 5 . 5 5 7 3 ± 2 4 . 9 9 3 4 
8 5 6 . 1 0 7 5 ± 1 3 . 5 4 5 5 6 2 . 1 2 1 2 ± 2 4 . 4 2 9 8 3 4 . 9 4 3 6 ± 2 4 . 7 9 3 2 
9 5 6 . 6 5 9 4 ± 1 4 . 2 4 3 2 6 3 . 2 4 8 4 ± 2 4 . 2 8 4 1 3 5 . 7 8 7 8 ± 2 4 . 8 8 6 4 
1 0 6 0 . 3 5 8 4 ± 1 2 . 3 0 3 4 6 4 . 8 4 9 3 ± 2 6 . 7 5 7 9 3 6 . 8 7 7 8 ± 2 6 . 1 8 2 
1 1 6 1 . 1 6 9 4 ± 1 1 . 0 0 2 4 6 6 . 2 3 7 9 ± 2 7 . 4 7 8 1 3 7 . 3 5 2 4 ± 2 6 . 7 7 8 7 
1 2 5 6 . 7 6 3 4 ± 1 3 . 2 4 4 5 6 6 . 3 4 8 1 ± 2 4 . 0 6 8 8 3 7 . 0 8 9 ± 2 5 . 3 8 1 2 
1 3 6 2 . 3 5 9 2 土 1 2 . 5 2 2 6 5 . 7 9 2 7 土 2 7 . 2 1 0 4 3 8 . 4 1 8 5 土 2 6 . 1 7 1 2 
1 4 6 2 . 4 0 0 2 ± 1 2 . 5 6 3 8 6 5 . 7 8 4 5 ± 2 7 . 0 4 0 7 3 8 . 6 8 7 1 ± 2 5 . 9 6 6 2 
1 5 6 3 . 1 8 2 5 ± 1 1 . 9 9 2 3 6 5 . 4 4 9 6 ± 2 7 . 5 1 6 3 3 8 . 9 0 6 1 ± 2 5 . 9 4 9 7 
Figure 4.24. a) Coronary flow rate recovery of ischemia-reperflision injured heart 
protected by D:F (7:3) and D:Y (7:3) compound formula at 8 mg/ml. b) Data are 
shown as mean 土 SD of 5 rat hearts for each group. 
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1 5 6 2 . 4 0 6 4 2 ± 1 1 . 9 9 2 3 4 5 . 7 8 1 2 8 ± 1 7 . 4 8 6 7 3 5 . 5 4 6 8 ± 1 7 . 4 7 0 9 
Figure 4.25. a) Coronary flow rate recovery of ischemia-reperfusion injured heart 
protected by FG and YG at 8 mg/ml. b) Data are shown as mean 土 SD of 5 rat hearts 
for each group. 
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4.2.2.3 Discussion: 
In this ischemia reperfusion (IR) model, four parameters were measured: leakage 
of CK and LDH, heart coronary flow rate recovery and heart contractile force recovery. 
They can also reflect the recovery of function of heart tissue after ischemia, which was 
mimicked in the procedure of stopping the buffer (Krebs solution) supply temporary. 
As mentioned, the leakage of CK and LDH can tell how serious the damage of the 
heart is. The heart contractile force recovery is also considered as one indicator. 
Post-ischemia contractile dysfunction or 'stunning' of the myocardium during 
reperfusion was originally described by Braunald and Kloner (1982). During period of 
stunning, left ventricular ejection fraction may be significantly impaired until recovery 
occurs. The precise mechanisms that cause stunned myocardial are poorly understood 
but may include the reduction in myocardium adenosine triphosphate levels as well as 
coronary microvascular plugging or endothelial disturbance with impaired 
microvascular responsiveness. The damage of myocardial will lead to the unsmooth of 
blood flow, so the recovery of the flow rate will also be studied. 
In Fig 4.18 - Fig 4.21, the leakage of CK and LDH were slightly decreased in the 
presence of both YG and D:Y (7:3) compound formula but not significant. The 
function of individual herbal extracts and its formula were negative. It suggested that 
both Yege and Fenge showed no protective effects for the myocardium at 8mg/ml. 
However, in the rest of parameters, four kinds of herbal extracts were not showed 
any positive effects. The recovery seemed to be even worsen than that of control one. 
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For the reason that only one concentration (8 mg/ml) were compared, the results would 
not be promising. Therefore, more dosages should be tested in the fiiture. 
The recovery of flow rate and contractile force were, disappointedly worsen than 
that injected herbs solution (control). This phenomenon may due to the carbohydrate 
suspension of extracts. YG and FG contain plenty of water-insoluble carbohydrate. 
The suspension will keep precipitating after centrifugation, they might stick at the wall 
of ventricle and affect the absorption of extracts by the tissue. 
Although this Langendorf experiment can be regarded as one part of antioxidative 
test, drug samples effect does not solely attribute to its antioxidant activity. According 
to Simon et al, 1996, xanthine oxidase inhibitors (refer to Fig 1.2 in chapter 1), vitamin 
E analogues and calcium antagonists can also elicit the protective effect. Calcium 
antagonists can help to recovery the loss of calcium homoeostasis in reperfused heart. 
Actually, calcium antagonists can also benefit in vasodilation and increase blood 
supply to the area at risk. Therefore, the vasodilative effect and protective function to 
IR-heart is closely co-related. 
To sum up, the results are inconclusive since only one concentration of drug 
samples were tested. Future confirmation using more dosages is needed. 
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Chapter 5 Comparison of Chemical Profiles of Pueraria thomsonii 
(Fenge) and Pueraria lobata (Yege) 
5.1 The Application of HPLC 
According to the previous parts, Yege and Fenge had the similar properties in 
terms of cardiovascular tonic effects. In order to have a better evaluation about it, High 
Performance Liquid Chromatography (HPLC) was applied. HPLC is a popular method 
of chemical analysis because it is easy to leam and is not limited by the volatility of the 
sample compound. It has many applications including separation, identification, 
purification, and quantification of various compounds. HPLC can also be regarded as 
one of an authentication method of herbal samples. 
HPLC utilizes a liquid mobile phase to separate the components of a mixture or 
herbal materials. These components are firstly dissolved in a solvent, and then forced 
to flow through a chromatographic column under a high pressure. In the column, the 
mixture is resolved into its components. The amount of resolution is dependent on the 
extent of interaction between the solute components and the stationary phase. The 
stationary phase is defined as the immobile packing material in the column. The 
interaction of the solute with mobile and stationary phases can be manipulated through 
different choices of both solvents and stationary phases. As a result, HPLC acquires a 
high degree of versatility not found in other chromatographic systems and it has the 
ability to easily separate a wide variety of chemical mixtures. 
Herbal materials consist of many components. 'Marker' compounds, therefore, 
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are necessary to be selected by manufacturers as a marker for quality control purpose 
(Ho and Zheng, 2002). The selection may be based on a variety of different factors 
such as the stability of the constituent, technical ease of analysis, amount of time and 
cost of analysis, utility in confirming identification of the component herbals, potential 
relevance to therapeutic effect and indicator of product quality. 
According to the Chinese Pharmacopoeia (2005 edition), Yege is identified to 
contain more than 2.4% of puerarin (C21H20O9) under the recommended HPLC test, 
while that of Fenge contains more than 0.3%. Puerarin is then the marker of Yege and 
Fenge. For Danshen, the genuine species should contain not less than 0.2% of 
tanshinone IIa (C19H18O93). 
- 1 2 8 -
HPLC Chromatographs of Danshen and Gegen 
5.2 H P L C Standardization 
There are a number of active components identified from Danshen, such as the 
lipid-soluble compounds tanshinone 11八(marker), tanshinones I，tanshinones IIB, 
water-soluble compounds protocatechualdehyde, salvianolic acid B and lithospermic 
acid as shown in figure 5.1. Some common chemicals were found in both Yege and 
Fenge (Jiang et al 2004). Most of them are isoflavones or their derivatives, such as 
puerarin (marker), daidzin, daidzein and genistein as shown in figure 5.2. 
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〇 〇 
〇 , 人 广 3 〇 , 人 / C H 3 
C H 3 R 1 
Tanshinone I Tanshinone II 
A: R1 = CH3 
B: R1 = CH2OH 
Figure 5.1. Structures of some active components from Danshen. 
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Figure 5.2. Structures of some active components from Yege and Fenge. 
Remark: glc represents glucose. 
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5.2.1 Materials and methods 
Chemicals 
Solvent A is HPLC grade water with 0.5% acetic acid. Solvent B is HPLC grade 
acetonitrile. Solvent A and B were degassed for an hour before use. Puerarin standard, 
Protocatechualdehyde standard, Salvianolic acid B standard, daidzein standard and 
Tanshinone IIA were purchased from National Institute of the Control of 
Pharmaceutical of Biology Products, Beijing, China. Daidzin standard, however, was 
purchased from Fluka. 
HPLC conditions 
A Beckman ODS 5\im, 4.6mm x 250mm column was employed using a linear 
gradient solvent system. Acetonitrile / Water was used as the mobile phase. The flow 
rate was 1 ml/min and the chromatogram was detected with an UV-detector at UV 254 
nm and 280 nm. For the reason that the retention time for daidzein was long (for 
almost an hour), the mobile phase was adjusted as follow: 0-25minute 1-50% B; 
25-30min 50%-90% B; 30-40min isocratic 90% B 
Sample preparation 
The extracts and standard marker compounds were dissolved in HPLC grade 
water. They were passed through a 0.22 pore size filter before injecting to the 
HPLC system. The volume injected each time was lOjiil. 
Statistical analysis 
All the calculations in the following were analyzed by Excel. 
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5.2.2 Results 
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Figure 5.3. HPLC chromatogram (280 nm) of Protocatechualdehyde standard. 10 |il of 
Protocatechualdehyde was injected. The peak of Protocatechualdehyde was shown at 
retention time 11.8 min. 
Protocatechualdehyde was scanned by 280nm in HPLC chromatogram while 
other chemicals were detected by 254nm wavelength. Protocatechualdehyde was 
insensitive under UV chromatogram at 254 nm. 
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Figure 5.4. HPLC chromatogram (254 nm) of Puerarin standard. 10 jil of puerarin was 
injected. The peak of Puerarin was shown at retention time 12.8 min. 
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Figure 5.5, HPLC chromatogram (254 nm) of daidzin standard. 10 |li1 of daidzin was 
injected. The peak of daidzin was shown at retention time 14.333 min. 
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Figure 5.6. HPLC chromatogram (254 nm) of daidzein standard. 10 [i\ of daidzein was 
injected. The peak of daidzein was shown at retention time 20.8 min. 
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Figure 5.7. HPLC chromatogram (254 nm) of salvianolic acid B (SAB) standard. 10 
of SAB was injected. The peak of SAB was shown at retention time 18.817 min. 
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B. HPLC chromato2raphs of herbal aqueous extracts 
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Figure.5.9. HPLC chromato gram (254 nm) of D:Y (7:3) aqueous extract 10 [i\ of 1 
mg/ml extract was injected. 
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Figure.5.10. HPLC chromatogram (254 nm) of D:F (7:3) aqueous extract 10 |il of 1 
mg/ml extract was injected. 
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Figure.5.11. HPLC chromatogram (254 run) of FG aqueous extract 10 |il of 1 mg/ml 
extract was injected. 
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Figure.5.12. HPLC chromatogram (254 nm) of YG aqueous extract 10 |il of 1 mg/ml 
extract was injected. 
The different pecks between YG and FG are 3 ‘ -methoxypuerarin and 
3,-hydroxypuemrin (compared the HPLC chromatogram with Jiang et al, 2004). 
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Figure.5.13. HPLC chromatogram (254nm) of DS aqueous extract 10 jil of 1 mg/ml 
extract was injected. 
The marker of Danshen: tanshinone IIA was water insoluble. Therefore, in this 
aqueous extract sample the peak of tanshinone IIA was not expected in the HPLC 
chromatogram. 
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C. Calibration curve of peak area against concentration 
For each pure compound, their chromatogram was detected at 254 nm or 280nm 
wavelengths. Several concentrations of each compound were tested and the 
relationship between their peak areas and corresponding concentrations were used to 
plot as calibration curve. It helped to determine the percentage content of compounds 
in different herbal extracts. 
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Figure 5.14 Calibration curve of protocatechualdeyde. [Peak area (280nm) VS 
concentration" 
(lOOOppm = 1 mg/ml) 
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Figure 5.15 Calibration curve of puerarin. [Peak area (254nm) VS concentration] 
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Figure 5.16 Calibration curve of daidzin. [Peak area (254nm) VS concentration: 
SAB 
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Figure 5.17 Calibration curve of salvianolic acid B (SAB). [Peak area (254nm) VS 
concentration" 
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Figure 5.18 Calibration curve of daidzein. [peak area (254nm) VS concentration； 
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The theme in this chapter is to compare the chemical contents of Yege and Fenge, 
as well as to co-relate the relationship between the biological effects of herbs and their 
chemical profiles. In the following, the percentage content of major compounds found 
in Yege, Fenge, Danshen and two compound formulae were calculated. 
~2 D:F(7:3) D : Y ( 7 : 3 ) ^ Compound Calibration curve ^ 
(% content) (% content) 
Daidzein y=86231 x-14678 0.9999 <0.022* 0.031 
Daidzin y=45853x-21074 0.9999 <0.063* 0.467 
Puerarin y=55498 %-26123 0.9999 0.134 1.724 
SAB y-12811 %-31554 0.9979 4752 3.824 
Table 5.1 Quantitative analysis data of daidzein, daidzin, puerarin and SAB in 
compound formulae. 
* The peak areas of daidzein and daidzin from D:F (7:3) compound formula were both 
out of the range in calibration curve (Fig 5.16 and Fig 5.18). The calculation of the 
percentage content of these two chemicals, therefore, not as accurate as expected. The 
percentage contents of daidzein and daidzin thus be determined as lower than 0.022% 
and 0.063%, respectively. 
The amount of daidzein, daidzin and puerarin in D:Y (7:3) were more than that of 
D:F (7:3). It suggested that the quantity of D:Y (7:3) was superior than that of D:F 
(7:3). 
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**30% Content **30% C o n t e n t ^ Content Content Compound (FG) inD:F (7:3) (YG) in D:Y in FG (%) in YG (%) 
(%) (7:3)(%) 
Daidzein 0.073 0.022 <0.022* 0.266 0.080 0.031 
Daidzin 0.205 0.061 < 0.063* 2.220 0.666 0.467 
Puemrin 0.784 0.235 0.134 9.400 2.820 1.724 
Table 5.2 Comparison of chemical contents between compound formulae and their 
corresponding FG / YG. extracts. 
** This is the theoretical percentage of certain compounds in the formula. For example, 
the theoretical percentage content of puerarin in D:Y (7:3) = 9.4 % (in YG) x 30% = 
2.82 o/o 
C o n t e n t * * 7 0 % Content Content Compound 
in DS (%) (DS) in D:F (7:3) (o/o) inD:Y(7:3) (%) 
SAB 4.321 3.025 4.763 3.824 
Table 5.4 Comparison of chemical contents between compound formulae and their 
corresponding individual DS extract. 
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5.2.3 Discussion 
In this chapter, two issues were focused, they are 1) Does Yege contain more 
compounds in terms of quality and quantity so that it elicited greater cardiovascular 
tonic effects? And 2) Does the compound formula lead to the new compounds or 
different amount of certain chemicals, which may lead to the observed synergistic 
vasodilative effect? 
Firstly, both D:F (7:3) and D:Y (7:3) contained salvianolic acid B and the peak for 
these this compound was higher in D:Y (7:3). For Fenge and Yege aqueous extracts, 
two compounds were not found in FG in contrast to the presence in Yege. They are, 
namely, 3‘-hydroxypuerarin and 3'-methoxypuerarin (Fig 5.13 and Fig 5.15). This 
result strongly encouraged us to further investigate Yege as they were suspected to be 
the reason behind why Yege possesses greater pharmaceutical effect. 
From the results, the chemical profiles of YG and FG were not significantly 
different from those of compound formulae. Some of the compounds extracted from 
formula were less than those from individual herbs. However, the percentages of SAB 
were higher in both compound formulae than that of individual DS extract (table 5.4), 
which revealed that the heating process led to the increase of SAB extraction. In 
vasodilation study (chapter 3), SAB was tested and showed positive effect, which 
could be co-related to these HPLE profiles that this active component made compound 
formula perform better (when compared to individual DS) in vasodilation experiment. 
However, the positive effect of daidzin could not be explained solely by the 
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HPLC analysis. Apart from the few tested compounds, the vasodilative and 
cardiovascular tonic effects of herbs may be attributed to some other compounds 
such as 3 '-methoxypuerarin and 3 '-hydroxypuerarin (only found in Yege). 
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Figure.5.8. HPLC chromatogram (254 nm) of tanshinone IIA standard. 10 [d of 
tanshinone IIA was injected. The peak of tanshinone IIA was shown at retention time 
36.333 min. 
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Figure.5.9. HPLC chromatogram (254 nm) of D:Y (7:3) aqueous extract 10 |il of 1 
mg/ml extract was injected. 
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Figure.5.10. HPLC chromatogram (254 nm) of D:F (7:3) aqueous extract 10 |il of 1 
mg/ml extract was injected. 
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Figure.5.11. HPLC chromatogram (254 nm) of FG aqueous extract 10 jil of 1 mg/ml 
extract was injected. 
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Figure.5.12. HPLC chromatogram (254 nm) of YG aqueous extract 10 \x\ of 1 mg/ml 
extract was injected. 
The different pecks between YG and FG are 3 ‘ -methoxypuerarin and 
3 ‘-hydroxypuerarin (compared the HPLC chromatogram with Jiang et al, 2004). 
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Figure.5.13. HPLC chromatogram (254nm) of DS aqueous extract 10 |il of 1 mg/ml 
extract was injected. 
The marker of Danshen: tanshinone IIA was water insoluble. Therefore, in this 
aqueous extract sample the peak of tanshinone IIA was not expected in the HPLC 
chromatogram. 
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C. Calibration curve ofpeak area against concentration 
For each pure compound, their chromatogram was detected at 254 nm or 280nm 
wavelengths. Several concentrations of each compound were tested and the 
relationship between their peak areas and corresponding concentrations were used to 
plot as calibration curve. It helped to determine the percentage content of compounds 
in different herbal extracts. 
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Figure 5.14 Calibration curve of protocatechualdeyde. [Peak area (280nm) VS 
concentration] 
(lOOOppm = 1 mg/ml) 
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Figure 5.15 Calibration curve of puerarin. [Peak area (254nm) VS concentration； 
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Figure 5.18 Calibration curve of daidzein. [peak area (254nm) VS concentration] 
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The theme in this chapter is to compare the chemical contents of Yege and Fenge, 
as well as to co-relate the relationship between the biological effects of herbs and their 
chemical profiles. In the following, the percentage content of major compounds found 
in Yege, Fenge, Danshen and two compound formulae were calculated. 
~2 D:F (7:3) D:Y(7:3) 
Compound Calibration curve ^ � 
(% content) (% content) 
Daidzein y=86231 x-14678 0.9999 <0.022* 0.031 
Daidzin y=45853x-21074 0.9999 <0.063* 0.467 
Puerarin y=55498 x-26123 0.9999 
SAB y=12811 x-37554 0.9979 3 ^ 4 
Table 5.1 Quantitative analysis data of daidzein, daidzin, puerarin and SAB in 
compound formulae. 
* The peak areas of daidzein and daidzin from D:F (7:3) compound formula were both 
out of the range in calibration curve (Fig 5.16 and Fig 5.18). The calculation of the 
percentage content of these two chemicals, therefore, not as accurate as expected. The 
percentage contents of daidzein and daidzin thus be determined as lower than 0.022% 
and 0.063%, respectively. 
The amount of daidzein, daidzin and puerarin in D:Y (7:3) were more than that of 
D:F (7:3). It suggested that the quantity of D:Y (7:3) was superior than that of D:F 
(7:3). 
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**30% Content **30% Content Content Content Compound (FG) inD:F (7:3) (YG) inD:Y in FG (%) in YG (%) (%) (7:3)(%) 
Daidzein 0.073 0.022 < 0.022* 0.266 0.080 0.031 
Daidzin 0.205 0.061 < 0.063* 2.220 0.666 0.467 
Puerarin 0.784 0.235 0.134 9.400 2.820 1.724 
Table 5.2 Comparison of chemical contents between compound formulae and their 
corresponding FG / YG extracts. 
** This is the theoretical percentage of certain compounds in the formula. For example, 
the theoretical percentage content of puerarin in D:Y (7:3) = 9.4 % (in YG) x 30% = 
2.82 % 
C o n t e n t * * 7 0 % Content Content 
Compound ^^^ (。/。） p g ) in D:F (7:3) (%) in D:Y (7:3) (%) 
^ 4 ^ 1 3.025 4.763 3.824 
Table 5.4 Comparison of chemical contents between compound formulae and their 
corresponding individual DS extract. 
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5.2.3 Discussion 
In this chapter, two issues were focused, they are 1) Does Yege contain more 
compounds in terms of quality and quantity so that it elicited greater cardiovascular 
tonic effects? And 2) Does the compound formula lead to the new compounds or 
different amount of certain chemicals, which may lead to the observed synergistic 
vasodilative effect? 
Firstly, both D:F (7:3) and D:Y (7:3) contained salvianolic acid B and the peak for 
these this compound was higher in D:Y (7:3). For Fenge and Yege aqueous extracts, 
two compounds were not found in FG in contrast to the presence in Yege. They are, 
namely, 3'-hydroxypuerarin and 3'-methoxypuerarin (Fig 5.13 and Fig 5.15). This 
result strongly encouraged us to further investigate Yege as they were suspected to be 
the reason behind why Yege possesses greater pharmaceutical effect. 
From the results, the chemical profiles of YG and FG were not significantly 
different from those of compound formulae. Some of the compounds extracted from 
formula were less than those from individual herbs. However, the percentages of SAB 
were higher in both compound formulae than that of individual DS extract (table 5.4), 
which revealed that the heating process led to the increase of SAB extraction. In 
vasodilation study (chapter 3), SAB was tested and showed positive effect, which 
could be co-related to these HPLE profiles that this active component made compound 
formula perform better (when compared to individual DS) in vasodilation experiment. 
However, the positive effect of daidzin could not be explained solely by the 
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HPLC analysis. Apart from the few tested compounds, the vasodilative and 
cardiovascular tonic effects of herbs may be attributed to some other compounds 
such as 3 '-methoxypuerarin and 3‘-hydroxypuerarin (only found in Yege). 
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Chapter 6 Summaries, Discussion and prospects 
6.1 Summaries and Discussion 
In this project, the results could be summarized as followed: 
A. Vasodialation study 
1. In comparison of the vasodilative effects of Fenge, Danshen and compound 
formula, the effective were compound formula D:F (7:3) > Danshen > Fenge. 
2. D:F (7:3) compound formula shown dose-dependent as well as synergistic 
vasodilative effects in organ bath experiment. 
3. The vasodilative function of Fenge was mediated by NO synthase pathway but 
not cycooxygenase-related. 
4. The vasodilative function of Danshen was endothelium-independent. 
5. The involvements of alpha! and betai adrenoceptors could be excluded from the 
vasodilative effects of Danshen and Fenge herbal extracts. 
6. The vasodilation of Fenge was via the stimulation of the voltage-sensitive K+ 
(Kv) channel and voltage-dependent inward rectifier K+ (Km) channel, and 
suspected to involve KATP channel. 
7. The vasodilative effect of Fenge is multifactial. 
8. The effect of Danshen was suspected to partially involve the opening of 
potassium channels. 
9. Daidzin and salvianolic acid B were potential active compounds from Fenge and 
Danshen, respectively. For daidzin, it was further tested for its involvement in 
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potassium channel. 
B. Comparison between Yege and Fenge for their cardiovascular tonic effects 
1. In the comparison between individual Yege, Fenge and between D:Y (7:3), D:F 
(7:3). Yege and D:Y (7:3) showed better potency in vasodilation study. 
2. The underlying mechanism of Yege and Fenge were the same with disparate 
degree of effect. 
3. The antioxidative activities of D:Y (7:3) and D:F (7:3) were no different. Yege 
and Fenge had almost negative effect in lower dosage while Yege started to show 
antioxidative activity in higher concentration (from 600|ig/ml) in the inhibition 
of AAPH induced RBC hemolysis experiment. 
4. In ischemia reperfusion experiment, Yege and D:Y (7:3) showed a little reduction 
of CK and LDH leakage from cardiomyocytes, which means they protected the 
heart cells from damage after ischemia reperfusion injury. 
5. All extracts showed no promising effects in the recovery of coronary flow rate 
and recovery of heart contractile force in test concentration. 
C, Comparison between Ye2e and Fen2e for their HPLC chromatographs 
1. Both D:F (7:3) and D:Y (7:3) contained salvianolic acid B and puerarin, active 
compound in vasodilative test and marker of Fenge / Yege , respectively. 
2. Generally, the peaks of SAB and puerarin were higher in D:Y (7:3). For Fenge 
and Yege aqueous extracts, two compounds were only found in Yege but not in 
Fenge. They are 3'-hydroxypuerarin and 3'-methoxypuerarin. 
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6.2 Prospects 
6.2.1 Cardiovascular tonic effect of pure compounds, extracts with different 
solvents and their vasodilative mechanism. 
Inspired from the differences between HPLC profiles of Pueraria lobata (Willd.) 
Ohwi (Yege) and Pueraria thomsonii Benth (Fenge) (chapter 5), the additional work 
will be required to document the effects of those compounds only existing in Yege. 
The greater cardiovascular tonic effect of Yege may attribute to the compounds 
(3'-hydroxypuerarin and 3‘-methoxypuerarin) that were not found in Fenge. 
Pure compounds will be more specific for their target receptors and pathways 
involved. Therefore, salvianolic acid B and Daidzin, which showed positive 
vasodilative effect in the aorta rings organ bath experiment, will be focused on their 
underlying mechanism in future. 
In this project, water extract was prepared for the reason that it was commonly 
used in traditional medicines and dietary supplements. However, in the modernization 
of Chinese herbs, herbs are always extracted with organic solvents such as ethanol 
and methanol. They are claimed to have better biological and pharmaceutical effects 
than those extracted from water since some organic components can also be extracted. 
In order to figure out the cardiovascular tonic effects of the organic solvent extracts of 
compound formula, different concentrations of ethanol (100%, 75%, 50% and 25%) 
are proposed to extract the herbal mixture and perform different tests. 
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6.2.2 Macrophage Foam Cell and Atherosclerosis 
Macrophages take up lipids and modified low-density lipoproteins (LDL), such 
as oxidized LDL and acetylated LDL (Ac-LDL), via the scavenger receptor (SR), 
resulting in the formation of foam cells (Krieger and Herz, 1994). The accumulation 
of these foam cells is implicated in the atherosclerosis process. Macrophages' cell 
surface receptors that mediate lipoprotein uptake differ in their specificity for 
lipoprotein particles. The class A scavenger receptors (SR-A) preferentially bind 
chemically modified LDL such as oxidized LDL. Incubation of macrophages with 
modified LDL results in unregulated cholesterol accumulation and foam cell 
formation (Brown et al, 1980). Thus, SR-A-mediated internalization of modified LDL 
is considered a key in atherosclerosis process. 
Strong in vivo (Kurwska and Manthey, 2004) and in vitro (Wilcox et al, 2001) 
evident now exists to indicate that citrus flavonoids could reduce the occurrence of 
cardiovascular disease through their ability to reduce hepatic production of cholesterol 
containing lipoproteins (Wilcox et al, 2001), and hence reduce total plasma 
cholesterol concentrations. 
Fenge and Yege contain plenty of isoflavonoids which derivate from flavonoids. 
The anti-atherogenic effects of flavonoids imply that these two herbs may also play a 
role in preventing foam cell formation. 
Preliminary results (data not shown) suggested that the treatment of 
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Sprague-Dawley rat macrophages with compound formulae D: Y (7:3) and D: F (7:3), 
can somehow inhibit the form cell formation by co-incubating the cells with acLDL 
and staining with Oil red O. Normal macrophages do not contain high level of neutral 
lipids and are not colored with Oil red O, a dye specific for neutral lipids (Philippe de 
Medina et al 2004). Normal macrophages do not contain a high level of vacuoles in 
their cytoplasm. When macrophages were treated with acLDLs, they became highly 
colorable with Oil red O and were full of lipid droplets and whorls, which is 
characteristic of foam cells (Tabas, 2002). In the presence of drugs, the decrease of 
accumulation of lipid droplets indicated that certain drugs can prevent foam cell 
formation process. 
There are so many ways to evaluate and to explain the inhibitory effect of the 
herbal extracts for the foam cells formation. One method is to assess the possibility of 
the herbal extracts to decrease SR-A expression of macrophages. SA-R can be 
detected by immunoblotting using the SR-A-specific polyclonal antibody (Stewart C 
et al, 2005). 
The development of atherosclerosis lesions is associated with an 
over-accumulation of cholesteryl esters in macrophages and smooth muscle cells in 
atherosclerotic lesions (Philippe de Medina et al, 2004). The formation of cholesteryl 
esters is catalyzed by acyl-CoA: cholesterol acyltransferase (ACAT) using both 
cholesterol and long-chain fatty acyl-coenzyme A as substrate (Chang et al, 1997). 
ACAT activity is present in variety of tissues including the intestinal mucosa, liver 
and macrophages (Chang et al 2001). Two isoforms have been described: ACAT-1 
and ACAT-2. ACAT-1 is the major isoform in macrophages and in the liver in human 
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(Chang et al, 2001). As the cholesteryl ester synthesis is greatly enhanced during the 
foam cell formation, to assess the activity of AC AT-1 under the influence of herbal 
extracts is a good way to investigate the possibility of the drug's inhibitory effect of 
foam cell formation. ACAT-1 can be extracted from rat liver's microsomes. Assays for 
ACAT activity were performed by measuring the formation of cholesteryl [nCjoleate 
from the endogenous cholesterol in the microsomal fraction with exogenous 
[I4C]oleyl-coA as the substrate (Philippe de Medina et al, 2004). 
The above experiments will be carried out in order to figure out the possibility 
for the herbal extracts to attribute to the prevention of cardiovascular disease. 
-151 -
Summaries. Discussion and Prospects 
6.2.3 The D:F (7:3) and D:Y (7:3) compound formulae capsule with GMP 
The quality of pharmaceuticals has been a concern of the World Health 
Organization (WHO) since its inception. The setting of global standards is requested 
in Article 2 of the WHO Constitution which cites: "develop, establish and promote 
international standards with respect to food, biological, pharmaceutical and similar 
products." It is the rationale for WHO to establish GMP — good Manufactory 
Practices. 
One of the mainstreams of the modernization of Chinese Medicine is turning 
herbal extracts to capsule format. The D:F (7:3) compound formula capsules as shown 
in figure 6.1, 500 mg extract encapsulated each, were manufactured with compliance 
to GMP by Hong Kong Institution of Biotechnology (HKIB). Under the GMP 
standard, they are ensured to be free of heavy metals, left-over pesticides and 
micro-organisms. The materials should be examined by visual and chemical 
parameters. The amount of active ingredients should be monitored by bioassays 
(Ken's thesis, 2003). 
As GMP was the international recognitions, the quality of capsules have been 
guaranteed and would be easily accepted by western world market 
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Figure 6.1. The D:F (7:3) compound formula capsules manufactured by HKIB. 
According to the summaries in this project, the cardiovascular tonic effect of 
Yege was superior to that of Fenge. (Fenge was used in the very beginning of the 
project since it was easily available in Hong Kong markets as well as for its easier to 
conduct quality control). Therefore, next we should step forward to the possibility of 
developing D:Y (7:3) as capsules for patients with cardiovascular diseases, especially 
those suffering from hypertension. 
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